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1. INTRODUCTION 
1.1  STOMACH  
 The gastrointestinal tract is one of the major exocrine systems 
in the body. Stomach is a J- shaped most dilated part of the alimentary 
canal, situated between oesophagus and small intestine, which 
reserves food and helps in digestion. It is situated directly under the 
diaphragm in the epigastric, umbilical and left hypochondriac regions 
of the abdominal cavity. The stomach is continuous with the 
esophagus at the cardiac sphincter and with the duodenum at the 
pyloric sphincter. In the stomach, digestion of starch continues, 
digestion of protein and triglycerides begins, the semisolid bolus 
converts to liquid and certain substances are absorbed (Ghosh, 2007; 
Waugh and Grant, 2006). 
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Fig 1: Anterior view of stomach (Tortora and Derrickson, 2006)  
1.1.1  Anatomy of stomach 
 The stomach is divided into four regions – 
Cardia  :  It surrounds the superior opening of the stomach. 
Fundus :   The left portion of the cardia is fundus. 
Body  :    It is large central portion of the stomach, inferior to 
the fundus. 
Pyloric part  :  It is the region of stomach that connects to the 
duodenum. It is divided into two parts  
i. Pyloric antrum – connects to the body of stomach. 
ii. Pyloric canal    – leads into duodenum. 
 The pylorus joined with duodenum via a sphincter called 
pyloric sphincter, which guards the opening between stomach and 
duodenum. When the stomach is inactive the pyloric sphincter is 
relaxed and open, and when the stomach contains food the spincter is 
closed. The concave medial border of the stomach is called the lesser 
curvature and the convex lateral border is called the greater curvature 
(Tortora and Derrickson, 2006). 
1.1.2  Histology of stomach 
 The wall of stomach consists of four usual layers 
Gastric mucosa – The surface of the mucosa is a layer of simple 
columnar epithelial cells called surface mucosa cells. It contains 
areolar connective tissue called lamina propria and smooth muscle 
called muscularis mucosae. The epithelial cells extend down into the 
lamina propria, when they form columns of gastric secretary cells 
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called gastric glands, which line many narrow channels called gastric 
pits.  The gastric glands have three types of exocrine glands –  
a) Mucous neck cells – secretes mucus 
b) Chief cells – secretes pepsinogen and gastric lipase 
c) Perietal cells – produce intrinsic factor and hydrochloric acid 
 In addition, gastric glands include a type of enteroendocrine cell 
called G cell, which is located mainly in the pyloric antrum and 
secretes the hormone gastrin into blood stream.  
Submucosa – the submucosal layer of stomach composed of aerolar 
tissue. 
Muscularis external – It consists of 3 layers 
i.  Outer – Longitudinal layer 
ii. Middle – Circular layer  
iii. Inner  – Oblique layer 
Serosa – Serosa composed of simple squamous epithelial cell called 
mesothelium and areolar connective tissue. Serosa covers the visceral 
peritoneum portion of the stomach (Tortora and Derrickson, 2006). 
1.1.3 Functions of stomach 
 Stomach stores the food temporarily so that digestive enzymes 
and pepsin can act on the food for digestion. Mechanical breakdown 
of food by all the three smooth muscles enable the stomach to act as a 
churn. Stomach also regulates the passage of gastric contents into the 
duodenum. When the chyme is sufficiently acidified and liquefied, the 
pyloric antrum forces small jets of gastric contents through the pyloric 
sphincter into the duodenum. This sphincter is normally closed, 
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preventing backflow of chyme into stomach. The motility and 
secretion are regulated by parasympathetic nerve stimulation. The 
chemical digestion also takes place in stomach like pepsin converts 
protein to polypeptides. Limited absorption of water, alcohol and 
some lipid soluble drugs occur from stomach. Hydrochloric acid 
(HCl) present in the gastric juice kills the bacteria and other harmful 
substances and provide non specific defense against microbes. The 
intrinsic factor secreted in stomach is needed for absorption of vitamin 
B12. Stomach also secretes gastrin hormone.  Stomach provides the 
acidic environment which is required before absorption of iron 
(Waugh and Grant, 2006; Chatterjee, 1985). 
1.1.4  Gastric juice and its function 
 About 2-3 liters of gastric juice secreted daily by specialized 
secretary glands in the mucosa. The stomach secretes gastric juice and 
it contains –  
 Mineral salts and water – liquefies the swallowed food. 
 Mucus – prevent mechanical and chemical injury to the 
stomach by lubricating the contents and by acting as a barrier between 
stomach and corrosive gastric juice.  
 Hydrochloric acid – denatures the proteins (unfold) present in 
food partially, acidify the food and stops the action of salivary 
amylase, kills ingested microbes, provide acid environment needed for 
digestion by pepsinogen. 
 Pepsin – only proteolytic enzyme in the stomach. Pepsin is 
secreted in an inactive form called pepsinogen in the stomach. 
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Pepsinogens activate the pepsin by hydrochloric acid and by pepsin 
already present in stomach. They begin the digestion of protein by 
breaking them into smaller fragments. It acts at pH 1.5 to 3.5. 
 Intrinsic factor (a protein) – necessary for the absorption of 
vitamin B12.  
 Gastric lipase – splits the short-chain triglycerides in fat 
molecules into fatty acid and monoglycerides. Stomach also secretes 
gastrin into blood (Waugh and Grant, 2006). 
1.1.5  Phases of gastric secretion 
 The secretion of gastric juice occurs by 3 phase named cephalic, 
gastric and intestinal phase. The digestive activities also occur in this 
three overlapping phases.  
Cephalic phases 
   This flow of gastric juice occurs before food reaches the 
stomach. Smell, sight, thought or taste of food activates neural centers 
in the cerebral cortex, hypothalamus and brain stem.  
Gastric phase  
 The hormonal and neural mechanisms regulate the gastric phase 
of digestion. Hormonal regulation is stimulated by the presence of 
food the enteroendocrine cells in the pyloric antrum and duodenum 
secretes gastrin. Gastrin, circulating blood which supplies the 
stomach, stimulates the gastric glands to produce more gastric juice. 
Gastrin secretion is suppressed when the pH in the pyloric antrum falls 
to 1.5. Under neural mechanism, when stomach walls are distended or 
pH increases, the stretch receptors and chemoreceptors are activated. 
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From the stretch receptor and chemoreceptor, nerve impulses 
propagate to the submucosal plexus, where they activate 
parasympathetic and enteric neurons. The resulting nerve impulses 
cause waves of peristalsis and continue to stimulate the flow of gastric 
juice.  
Intestinal phase 
 This phase starts when partially digested food contents enter the 
small intestine from stomach. The two hormones secretin and 
cholecystokinin are produced by endocrine cells in intestinal mucosa 
and they slow down the secretion of gastric juice and reduce gastric 
motility. By slowing the emptying rate of the stomach, the contents of 
the duodenum become more thoroughly mixed with bile and 
pancreatic juice. This phase of gastric secretion is most marked 
following meal with high fat content (Waugh and Grant, 2006; Tortora 
and Derrickson, 2006).  
1.1.6  Physiology of gastric secretion  
 Gastric acid secretion is a complex, continuous process in 
which multiple central and peripheral factors contribute to a common 
endpoint: the secretion of H+ by parietal cells. The regulation of acid 
secretion by parietal cells is especially important in peptic ulcer and 
constitutes a particular target for drug action. The secretion of the 
parietal cells is an isotonic solution of hydrochloric acid (150 mmol/l).  
The Cl- is actively transported into canaliculi in the cell which 
communicate with the lumen of the gastric glands and thus with 
lumen. The Cl– secretion is accompanied by K+, which is then 
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exchanged for H+ from within the cell by a H+, K+ - ATPase. Carbonic 
anhydrase catalyses the combination of carbondioxide and water to 
give carbonic acid (HCO3¯ ), which dissociate into H+ and bicarbonate 
ions (Rang et al., 2003; Bevan and Thompson, 1983). 
H2O   +    CO2
carbonic anhydrase
H
+
   +   HCO3
-
 
 Secretion of gastric acid is accomplished by activity of an ion- 
motive ATPase that exchanges cytosolic H+ for luminal K+, resulting 
in acidification of extacellular surface of parietal cell and secretion of 
gastric juice. Parietal cell H+, K+ - ATPase, often designated the 
gastric ‘‘proton pump’’, derives its energy for transport of H+ and K+ 
from the hydrolysis of adenosine tri phosphate (ATP). In the parietal 
cell, the enzyme has access to the canalicular membrane that provides 
a pathway for inward K+ transport in exchanging for outer H+ 
transport. The transport activity of H+, K+-ATPase is regulated by 
levels of intracellular second messengers, either cAMP or calcium ion 
(Munson, 1995). 
 Neuronal (acetylcholine, ACh), paracrine (histamine), and 
endocrine (gastrin) factors all regulate acid secretion.  Their specific 
receptors (M3, H2, and CCK2 receptors, respectively) are on the 
basolateral membrane of parietal cells in the body and fundus of the 
stomach. The histamine (H2) receptor is a G-protein coupled receptor 
(GPCR) that activates the Gs-adenylylcyclase-cyclic AMP-PKA 
pathway. ACh and gastrin signal through GPCRs that couple to the 
Gq-PLC-IP3-Ca2+ pathway in parietal cells. In parietal cells, the cyclic 
  22
AMP and the Ca2+-dependent pathways activate H+,K+-ATPase (the 
proton pump), which exchanges hydrogen and potassium ions across 
the parietal cell membrane. This pump generates the largest known ion 
gradient in vertebrates, with an intracellular pH of about 7.3 and an 
intracanalicular pH of about 0.8 (Brunton et al., 2006). 
 
 
 
 
Acetylcholine (ACh), muscarinic (M), and nicotinic (N) receptors; gastrin, 
cholecystokinin receptor (CCK2); histamine (HIST), H2 receptor; and 
prostaglandin E2  receptor (EP3). The X indicates antagonism effect. ECL 
cell are enterochromaffin-like cell. The stimulatory effect (+) or inhibitory 
(-). 1 and 3 indicate possible inputs from postganglionic cholinergic fibers, 
while 2 shows neural input from the vagus nerve. 
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Fig 2: Regulation of acid secretion by parietal cells and the site of 
action of drugs (Brunton et al., 2006) 
1.1.7  Gastric defense system 
 A number of mechanisms adopted by the stomach to protect 
itself from acid induced damage. An adequate mucosal blood flow, 
oxygen requirements of the gastric mucosa is needed to protect the 
mucosa. Gastric mucus is an important factor for the gastric mucosa 
and consists of viscous, elastic, adherent and transparent gel formed 
by 95% water and 5% glycoprotein which cover the gastrointestinal 
mucosa. Moreover, mucus is capable of acting as an antioxidant and 
thus can reduce mucosal damage mediated by oxygen free radicals. 
The secretion of a mucus layer protects gastric epithelial cells. Gastric 
mucus secreted in soluble form but quickly forms an insoluble gel that 
coats the mucosal surface of the stomach, slows ion diffusion, and 
prevents mucosal damage by macromolecules such as pepsin (Repetto 
and Llesuy, 2002).  
 Secretion of mucus is stimulated by prostaglandins E2 and I2. 
Prostaglandins also directly inhibit gastric acid secretion by interacting 
with parietal cells, EP3 receptor which are negatively coupled to 
adenylyl cyclase by means of Gi protein. Prostaglandins inhibit the 
formation of cAMP and reduce the activity of H+,K+-ATPase.  
Prostaglandin also enhances mucosal blood flow. An important part of 
the normal mucosal defense is the secretion of bicarbonate ions by 
superficial gastric epithelial cells which neutralizes the acid in the 
region of the mucosal cells, thereby raising pH and preventing acid-
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mediated damage. Continued renewal of the mucosal cell layer is an 
important part of the defense system. Somatostatin also inhibits gastric 
secretion but the release of somastostatin is inhibited by acetylcholine. 
Nitricoxide also participates in the gastric defense mechanism. It 
increases the synthesis of prostaglandins in physiological and 
pathological conditions and influences the gastric mucosal blood flow 
and gastric mucus secretion (Gurbuz and Yesilada, 2007; Brunton et 
al., 2006; Clark et al., 1992).  
1.2  PEPTIC ULCER  
  Peptic ulcer disease is characterized by inflamed lesions or 
excavations of the mucosa and underlying tissue of the upper 
gastrointestinal tract. The ulcers are the result of damage to the mucus 
membrane that normally protects the esophagus, stomach and 
duodenum from gastric acid and pepsin (Brenner and Stevens, 2006). 
The pathophysiology of this gastro-intestinal disorder is viewed as an 
imbalance between mucosal defensive factors  such as bicarbonate, 
prostaglandin, nitric oxide, peptides, growth factors and injurious 
factors like acid, pepsin (Brunton et al., 2006; Goel and Sairam, 
2002). Gastric ulcer is often a chronic disease and may persist for 10-
12 years characterized by repeated episode of healing and re-
exacerbations (Rao et al., 2004).  
1.2.1  Epidemiology 
 Peptic ulcer is the most common, chronic gastrointestinal 
disorder and has become a common global health problem affecting a 
large number of people world wide and still a major cause of 
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morbidity and mortality (Chan and Leung, 2002). Geographically, the 
disease is prevalent throughout the world, in USA annually 3.7 million 
people are affected by this disease. 
 
Fig 3: Site of peptic ulcer in different parts of the stomach 
1.2.2  Factors causing peptic ulceration 
Gastric injury induced by NSAIDs 
 Non steroidal anti-inflammatory drugs (NSAIDs) are used 
widely in the treatment of pain, fever, inflammation, rheumatic and 
cardiovascular disease, and more recently for the prevention of colon 
cancer and Alzheimer’s disease. Chronic administration of these drugs 
is often associated with the development of adverse gastrointestinal 
effects, such as gastric erosions, gastric and duodenal ulceration and 
severe complications such as gastrointestinal hemorrhage and 
perforation. NSAIDs like aspirin, indomethacin is known to induce 
ulcer by inhibition of cyclooxygenase enzyme (COX) and suppression 
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of prostaglandin (PG) mediated effects on mucosal protection. 
Endogenous prostaglandins regulate the mucosal blood flow, 
epithelial cell proliferation, epithelial reconstitution, mucosal 
immunocyte function, mucus and bicarbonate secretion. Beside, these 
neutrophil and oxygen radical-dependant microvuscular injuries may 
be important processes that lead to mucosal damage in response to 
NSAIDs administration. These agents cause the activation of 
neutrophils and their adherence to the vascular endothelium, hence 
blocking capillaries and reducing local gastric blood flow. It also 
reduces the hydrophobicity of the mucus gel layer by changing the 
action of surface-active phospholipids. These drugs cause  
an increase in acid and pepsinogen secretion (Hiruma-Lima 
et al., 2006; Berenguer et al., 2006; Toma et al., 2005; Jainu and Devi, 
2004; Blandizzi  et al., 2005; Chang and Leung, 2002). 
Helicobacter pylori 
 Helicobacter pylori, a gram-negative rod, has been associated 
with gastritis and subsequent development of gastric and duodenal 
ulcers, gastric adenocarcinoma and gastric B-cell lymphoma (Brunton 
et al., 2006). Gastroduodenal diseases caused by H. pylori are 
associated with infiltration of gastric mucosa by neutrophil, 
lymphocyte, monocytes and plasma cell (Gooz et al., 2001) 
Stress 
 Stress plays an important role in etiopathology of gastro-
duodenal ulceration. Increase in gastric motility, vagal over activity; 
mast cell degranulation; decreased gastric mucosal blood flow; and 
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decreased prostaglandin synthesis; are involved in genesis of stress 
induced ulcers (Rao et al., 2004). Gastric stress ulceration is probably 
mediated by release of histamine with enhanced acid secretion and 
reduced mucus production (Toma et al., 2005).   
Smoking 
 Cigarette smoking can also increase the chance of getting an 
ulcer. Smoking also slows the healing of existing ulcer and contributes 
to ulcer reoccurrence (Clark et al., 1992; Walker and Taylor, 1979). 
Blood group 
 The incident of peptic ulcer is higher in the people having blood 
group O than those of blood groups A and B (Nelson and Cox, 2005; 
Bowman and Rand, 1980). 
Sex 
 Duodenal ulcer more commonly seen in man than in women, 
though gastric ulcer occurs to an equal extent in man and women 
(Bowman and Rand, 1980).  
Dietary factors  
Caffeine  
 The caffeine can stimulate acid secretion in stomach and can 
aggravate an existing ulcer.  
Alcohol 
 There is a little evidence of an association between alcohol use 
and peptic ulcer. Ulcers are common in people who have cirrhosis of 
the liver, a disease often linked to heavy alcohol consumption. 
Dietary salt 
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 The evidence was found between an association of gastric ulcer 
and dietary salts. The occurrence of gastric ulcer may be linked to the 
amount of dietary salt consumption. The salt was shown to induce 
gastritis of experimental animals (Duggan and Duggan, 2006; 
Sonnenberg, 1986). 
1.2.3  Treatment of peptic ulcer 
 Drugs employed in the treatment of peptic ulcer have three 
therapeutic aims (i) to relieve pain (ii) to accelerate healing and (iii) to 
prevent ulcer recurrence. Therefore three therapeutic approaches are to 
reduce aggressive forces by lowering H+ output, to increase protective 
forces by means of mucoprotectants and to eradicate H. pylori 
(Tripathi, 2003; Lullmann et al., 2000). 
Drugs used in the treatment of peptic ulcer 
1. Reduction of gastric acid secretion  
a) Proton pump inhibitors - Omeprazole, Pentoprazole  
b) H2 antihistamines - Ranitinide, Cimetidine, Famotidine  
c) Anticholinergics - Pirenzepine, Propantheline  
d) Prostaglandin analogues - Misoprostol, Enprostil, Rioprostil 
2. Neutralization of gastric acid (Antacids) 
a) Systemic - Sodium bicarbonate, Sodium citrate 
b) Non systemic - Magnesium hydroxide, Magnesium trisilicate, 
Aluminium hydroxide gel, Calcium carbonate. 
3. Ulcer protective agent   
 Sucralfate, Colloidal bismuth subcitrate 
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4. Ulcer healing drugs or cytoprotective agents 
 Carbenoxolone, Rebemipide 
5. Anti - H. pylori drugs  
  Amoxicillin, Clarithromycin, Metronidazole, Tinidazole, 
Tetracycline. 
1.2.4  Induction of experimental ulcer 
 Antiulcer activity can be evaluated in rats by employing the 
following methods (Parmar and Desai, 1993). They are broadly 
divided into 3 types– 
A) Gastric antiulcer study 
a)  Pylorus ligated ulcer (Shay rats) 
b)  NSAIDs induced gastric damage - Aspirin, Indomethacin, 
Phenylbutazone generally used to induce ulcer in rats. 
c)  Stress ulcer – like Restraint ulcers, water immersion-induced 
restraint ulcer, cold and restraint ulcers, swimming stress ulcers, 
activity stress ulcer. 
d)  Reserpine induced ulcer (chronic ulcer model) 
e)  Acetic acid induced chronic ulcer (chronic ulcer model) 
f)  Serotonin induced ulcer 
g)  Dimapit induced gastric ulcer 
h)  Endotoxin (Lipopolysaccharide B) induced gastric ulcer 
i)  Aspirin plus pylorus ligated ulcer - This is one of the useful and 
popular ulcer models. Aspirin like NSAIDs are one of the 
important factors which cause the ulcer in human and used in 
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animals to produce ulcer experimentally. Pylorus ligation also 
one of the important experimental ulcer model where increased 
amount of acid and pepsin causes ulcer. When aspirin is 
administered to pylorus ligated rats, it further aggravated the 
acidity and the resistance of the gastric mucosa was decreased 
thereby imposing extensive damage to the glandular region of 
the stomach (Sanmugapriya and Venkataraman, 2007). 
B)  Gastric cytoprotection study  
 The following methods are employed to produce mucosal injury 
in experimental animals and evaluate cytoprotective effect of drug. 
a)  30 mg of aspirin suspended in 0.15 M HCl 
b)  Absolute ethanol 
c)  0.6 M hydrochloric acid  
d)  25 % sodium chloride 
e)  80 mM of sodium taurocholate 
f)  Boiling water (thermal injury) 
C)  Duodenal anti-ulcer study 
 Duodenal ulcer can be induced by cysteamine, dulcerozine, 
dimaprit, 1–methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP), 
indomethacin plus histamine and through the subcutaneous (s.c) 
infusion of pentagastrin and carbachol. 
1.2.5   Effect of oxidative stress, free radicals in peptic ulcer 
 Oxygen derived free radical reactions have been implicated in 
the pathogenesis of many human diseases including neurodegenerative 
disorder, atherosclerosis, ischemic heart disease, ageing process, 
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inflammation, diabetes, immunodepression, neurodegenerative 
condition and also peptic ulcer (Bafna and Balaraman, 2005; 
Balaraman et al., 2004). ROS caused gastric damage by physical, 
chemical, psychological factors that lead to gastric ulceration in 
human and experimental animals (Rao et al., 2004) 
 Oxidative stress plays an important role in the pathogenesis of 
gastric ulcer. Oxidative stress is a harmful condition that occurs when 
there is an excess of ROS and/or a decrease in antioxidant levels (Tian 
et al., 2007). Reactive oxygen metabolites include true free radicals 
and other toxic compounds derived from oxygen metabolism, 
including hydrogen peroxide and hypochlorite (Davies and Rampton, 
1994). The ROS formed from several sources like mitochondrial 
cytochrome oxidase, xanthine oxidases, neutrophils and transitional 
metals. The reactive oxygen species generated by the metabolism of 
arachidonic acid, platelets, macrophages and smooth muscle cells may 
contribute to gastric mucosal damage. Oxygen free radicals are 
detrimental to the integrity of biological tissue and mediate their 
injury. The mechanism of damage involves lipid peroxidation, which 
destroys cell membranes with the release of intracellular components, 
such as lysosomal enzymes leading to further tissue damage. The 
radicals also promote mucosal damage by causing degradation of the 
epithelial basement membrane components, complete alteration of the 
cell metabolism. The damage to membrane proteins decreases 
membrane permeability, activities of enzymes and receptors and 
activation of cells (Sannomiya et al., 2005; Demir et al., 2003; 
Repetto and Llesuy, 2002; Ali et al., 1996). ROS play important role 
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in formation of gastric ulcers induced by stress, ethanol, NSAIDS, 
pylorus ligation and H. pylori infection. (Halici et al., 2005; Bafna and 
Balaraman, 2005).  
Reactive oxygen species includes – Radicals such as superoxide 
(O2•−), hydroxyl (OH•), peroxyl (RO2•), hydroperoxyl (HO2•), alkoxyl 
(RO•) and non radicals like hydrogen peroxide (H2O2), hypochlorous 
acid (HOCl), ozone (O3), singlet oxygen (1Δg), peroxy nitrate 
(ONOO−).  
 Superoxide anions (O2•−) is one of the important ROS, which 
is attributed in tissue and gastric damage and responsible for lipid 
peroxidation. Superoxide radicals also have the capability to decrease 
the activity of other antioxidant defense system enzyme such as 
catalase and glutathione peroxidase (GPx). Superoxide anions also 
cause damage to the ribonucleotide which is required for DNA 
synthesis. The protonated form of O2•− is HO2•, which is more reactive 
and able to cross the membrane and causes damage to tissue.  
 Hydrogen peroxide (H2O2) is not a radical but it produces 
toxicity to cell by causing DNA damage, membrane disruption and 
release calcium ions within cell, resulting in calcium dependent 
proteolytic enzyme to be activated. 
 Hydroxyl (OH•) radical is most reactive chemical species. It is 
a potent cytotoxic agent and able to attack and damage almost every 
molecule found in living tissue. One OH• can result in conversion of 
many fatty acid side chains into lipid hydroxyl peroxides.  
 Hypoclorous acid (HOCl) is produced by the enzyme 
myeloperoxidase in activated neutrophils and initiates the deactivation 
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of antiproteases and activation of latent proteases leading to tissue 
damage. It has ability to damage biomolecules, directly and also 
decomposes to liberate toxic chlorine (Halliwell and Gutteridge, 
1999).  
1.2.6  Role of antioxidant defense system in peptic ulcer 
 The body has developed several endogeneous antioxidant 
defence systems to deal with the production of ROS. The antioxidant 
enzymes play a major role in cell defense against acute oxygen 
toxicity. Their main function is to protect membrane and cytosolic 
components against damage caused by free radicals. This system is 
divided into two groups viz., enzymatic and non enzymatic. The 
enzymatic defense system include superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx), glutathione reductase 
(GR)  and the non enzymatic defense system included vitamin E, 
vitamin A, vitamin C and reduced glutathione (GSH) (Demir et al., 
2003, Harris, 1992). 
Superoxide dismutase (SOD) 
 Superoxide dismutase (SOD) is an important endogenous 
antioxidant enzyme act as the first line defense system against ROS 
which scavenges superoxide radicals. SOD catalyzes the dismutation 
of superoxide (O2• -) to H 2O 2 and O2.  
O2
.
  +  O2
.
  +  2H
+
H2O2  +  O2   
 Glutathione peroxidase (GPx) 
 Glutathione peroxidase present in the cytoplasm of the cells. It 
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consists of four protein subunits; each of which contains one atom of 
the element selenium at its active site. GPx remove H2O2 by coupling 
its reduction to H2O with oxidation of reduced glutathione (GSH). 
Thus it protects cell against oxidative injury caused by H2O2 and 
prevent the formation of hydroxyl radical from H2O2 (Halliwell and 
Gutteridge, 1999). 
H2O2  +  2GSH GSSG  +  2H 2O 
 GPx catalyse GSH dependent reduction of fatty acid 
hydroperoxides (eg, linoleic acid, cholesterol 7β - hydroperoxide) and 
various synthetic hydroperoxide. But it can not act upon fatty acid 
peroxides esterified to lipid molecule in lipoprotein or membrane. 
Glutathione reductase (GR) 
 The ratio of reduced to oxidized glutathione (GSH/GSSG) in 
normal cell is high so that there must be mechanism for reducing 
GSSG back to GSH. The reduction of GSSH to GSH is achieved by 
the enzyme glutathione reductase (GR) in the presence of NADPH.  
GSSG NADPH H
+
2GSH NADP
+
+ ++  
 The NADPH required is provided in both animal and plant 
tissue by several enzyme systems, the most important one is the 
oxidative pentose phosphate pathway. Glucose-6-phosphate 
dehydrogenase is the first enzyme in this pathway. 
 The rate at which the pentose phosphate pathway operates is 
controlled by the supply of NADP+ to Glucose-6-phosphate 
dehydrogenase (G6PD) (Halliwell and Gutteridge, 1999). 
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Glucose 6 - phosphate NADP
+
6 - phosphogluconate
NADP H
+
Followed by 6 - phosphogluconate dehydrogenase,
6 - phosphogluconate NADP
+ CO2 NADPH H
+
ribulose 5 - phosphate
+
+
+ +
+
+ +
Reduced glutathione (GSH)  
 Glutathione (GSH) is a tripeptide and a powerful antioxidant 
present within the cytosol of cells and is the major intracellular 
nonprotein thiol compound (NPSH). Glutathione is synthesized 
intracellularly from cysteine, glycine and glutamate. GSH is important 
in maintaining -SH groups in other molecules including proteins, 
regulating thiol-disulfide status of the cell, and detoxifying foreign 
compounds and free radicals. Sulfur containing amino acids like 
methionine and cysteine are precursors of GSH but also provide-SH 
groups to react with H2O2 and the OH• radical and may prevent tissue 
damage. GSH is capable of scavenging ROS directly or enzymatically 
via GPx (Demir et al., 2003; Ali et al., 1996 ).  
Vitamin C and E 
 The number of non-enzymatic endogenous antioxidant 
mechanisms also exists within normal cells such as vitamins C and E. 
They can react with free radicals to form radicals themselves which 
are less reactive than the radicals. They break radical chain reactions 
by trapping peroxyl and other reactive radicals. It is possible that these 
vitamins are consumed in the process of lipid peroxidation induced by 
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oxygen radicals in ischemia reperfusion to prevent the development of 
tissue damage (Ali et al., 1996). Removal of excess reactive species or 
suppression of their generation by antioxidants may be effective in 
preventing oxidative cell death (Tian et al., 2007). Antioxidants acts 
as a radical scavengers and inhibit lipid peroxidation and other free 
radical mediated process and protect the human body from several 
disease attributed to the reaction of radicals (Repetto and Llesuy, 
2002). 
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+ , Catalyses reaction; – , inhibites enzyme or scavenges reactive oxygen 
metabolites ; NADPH, nicotinamide adenine dinucleotide phosphate; 
DMSO, dimethylsulphoxide; SOD, superoxide dimutase; CAT, catalase, 
GPx, glutathione peroxidase; GSH, reduced glutathione; GSSH, oxidized 
glutathione. 
 
Fig 4: Pathway of reactive oxygen metabolite formation and site of 
action of some antioxidants (Davies and Rampton, 1994) 
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1.2.7  Role of phytomedicine in peptic ulcer 
 Herbal medicine is still the mainstay of about 75-80% of the 
world population, mainly in developing countries, for primary health 
care because of better cultural acceptability, better compatibility with 
the human body and lesser side effects. The chemical constituents 
present in the herbal medicine or plant are a part of the physiological 
functions of living flora and hence they are believed to have better 
compatibility with human body (Kamboj, 2000). Natural products 
from plants are a rich resource used for centuries to cure various 
ailments. The use of bioactive plant-derived compounds is on the rise, 
because the main preoccupation with the use of synthetic drugs is the 
side effects which can be even more dangerous than the diseases they 
claim to cure. In contrast, plant derived medicines are based upon the 
premise that they contain natural substances that can promote health 
and alleviate illness and proved to be safe, better patient tolerance, 
relatively less expensive and globally competitive. So, a retrospect of 
the healing power of plants and a return to natural remedies is an 
absolute requirement of our time (Sannomiya et al., 2007). Therefore, 
alternative approach in recent days is the research of medicaments 
from traditional medicine. The use of phyto-constituents as drug 
therapy to treat major ailments has proved to be clinically effective 
and less relatively toxic than the existing drugs and also reduces the 
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offensive factors serving as a tool in the prevention of peptic ulcer 
(Jainu and Devi, 2006). 
1.2.8  Combination therapy  
 For many years, the therapeutic superiority of a plant drug 
combination over a mono extract had only the support of practical 
experiences. The first approach toward rationalizing this multi drug 
therapeutic concept was made by Berenbaum (1989). He described 
that ‘a total effect of a combination is greater than expected from the 
sum of the effects of the single’ and ‘synergy is deemed present if the 
effect of a combination is greater than that of each of the individual 
agents’. Now a day’s combination therapy is one of the important 
practices in treatment of various diseases and combination therapy 
shows greater effect and efficacy than the single drug treatment 
(Wagner, 2006). Various studies showed that when herbal product is 
combined with modern drugs it produces better effect and reduces 
toxic effect resulting in better efficacy and treatment (Muniappan and 
Sundararaj, 2003). 
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1.3  DRUG PROFILE 
Gallic acid 
 Gallic acid belongs to the group of polyhydroxy phenolic 
compound. It is widely distributed in plant kingdom mainly in fruits 
and vegetables. Gallic acid is present as free molecule or as a part of 
the tannin molecule.  
Category 
 It is belongs to a class of phenolic compound. 
Sources 
 Gallic acid is found in many natural products like gallnuts, 
grapes, tea leaves, green tea, hops, oak bark, apple-peels, pineapples, 
bananas, lemons, strawberries, sumac, red and white wine, asparagus, 
broccoli and aubergine (Madlener et al., 2007). 
Molecular structure and chemical name 
COOH
OH
OH
OH
 
Gallic acid (3,4,5- trihydroxy benzoic acid (C7H6O5)) 
Uses 
 Gallic acid is a potent antioxidant and has wide range of 
biological activities (Yen et al., 2002). It is used as neuroprotective, 
anti-obesity, hepatoprotective, anti allergic, anti-inflammatory, 
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antifungal, antimicrobial and antiasthmatic agent (Ban et al., 2008; 
Hsu and Yen, 2007; Jadon et al., 2007; Kim et al., 2006; Ahn et al., 
2005; Dorsch et al., 1992). Gallic acid is important for its anticancer, 
chemoprotective, antitumor activity (Faried et al., 2007; Veluri et al., 
2006; Prasad et al., 2006; Isuzugawa et al., 2001, Inoue et al., 1994). 
Different plant and fruit extracts contains gallic acid as an important 
constituent, showing mutagenic, anti-diabetic and anti-ulcer activity 
(Sannomiya et al., 2007; Govindarajan et al., 2006; Sridhar et al., 
2005). 
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2. LITERATURE REVIEW 
Umamaheswari et al., (2007) evaluated the antiulcer activity of 
the ethanolic extract of Jasminum grandiflorum L. leaves (JGLE, 100 
and 200 mg/kg, b.w., p.o) on aspirin + pylorus ligation and alcohol 
induced acute gastric ulcer models and ulcer-healing activity using 
acetic acid induced chronic ulcer model in rats. The antioxidant 
activity of JGLE was also studied using DPPH assay, reductive 
ability, superoxide anion scavenging activity, nitric oxide scavenging 
activity and total phenolic content of the extract. The ulcerative lesion 
index significantly decreased (P<0.01) in all the three models in rats 
as compared to the standard drug famotidine (20 mg/kg, b.w. orally). 
A decrease in the gastric fluid and total acidity and an increase in the 
pH of the gastric fluid in aspirin plus pylorus ligation rats proved the 
antisecretary activity of JGLE. JGLE completely healed the ulcer 
within 20 days of treatment in acetic acid induced model like antiulcer 
activity, the free radical scavenging activities of JGLE depends on 
concentration and increased with increasing amount of the extract. The 
result suggests that the leaves of Jasminum grandiflorum possess 
potential antiulcer activity, which may be attributed to its antioxidant 
mechanism of action. 
 
Hsu and Yen (2007) investigated anti-obesity effect of gallic 
acid and beneficial effect of gallic acid in suppression of high-fat diet 
(HFD)-induced dyslipidaemia, hepatosteatosis and oxidative stress in 
male Wistar rats by feeding them a HFD.  Gallic acid (50 and  
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100 mg/kg) was given to two groups as a supplement for a period of 
10 weeks. A significant decrease in body weight, organ weight of the 
liver and adipose tissue weights of peritoneal and epididymal tissues 
was observed in the HFD + gallic acid groups when compared with 
HFD group. Serum triacylglycerol (TAG), phospholipid, total 
cholesterol, LDL-cholesterol, insulin and leptin levels were also 
decreased in similar manner. Histological study showed that the lipid 
droplets of rats with HFD + gallic acid diets were significantly smaller 
than those with HFD diets. The consumption of gallic acid also 
reduced oxidative stress and GSSG content and enhanced the levels of 
glutathione, glutathione peroxidase, glutathione reductase and 
glutathione S-transferase in the hepatic tissue of rats with HFD-
induced obesity.  
 
Jadon et al., (2007) reported that Terminalia belerica Roxb. 
and gallic acid protects liver and kidney against carbon tetrachloride 
induced damage in albino rats. After administration of carbon 
tetrachloride a significant increase in the serum transaminases, serum 
alkaline phosphatase activity and hepatic lipid peroxidation and a 
significant depletion in reduced glutathione level were observed. A 
minimum elevation was found in protein content and a significant fall 
was observed in glycogen content of liver and kidney after toxicant 
exposure. Adenosine triphosphatase and succinic dehydrogenase 
activities were also inhibited significantly in both the organs after 
toxicity. Treatment with plant extract (200, 400 and 800 mg/kg, p.o.) 
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and gallic acid (50, 100 and 200 mg/kg, p.o.) showed dose-dependent 
recovery in all these biochemical parameters but the effect was more 
pronounced with gallic acid.  
 
Madlener et al., (2007) examined cytotoxic and biochemical 
effects of gallic acid on the human HL-60 promyelocytic leukemia cell 
line.  Gallic acid (GA) is a naturally occurring polyhydroxyphenolic 
compound and an excellent free radical scavenger. Gallic acid inhibits 
ribonucleotide reductase by causing significant imbalance of 
deoxynucleosidetriphosphate (dNTP) pool sizes. Gallic acid (80 mM) 
induced dose-dependent apoptosis (39% cells) in HL-60 cells and 
gallic acid (60 mM) attenuated progression from G0/G1 to the S phase 
of the cell cycle. The IC50 values of gallic acid were 3.5 and 4.4 nM 
for the inhibition of cyclooxygenases I and II, respectively. Highly 
synergistic growth inhibitory effects could be observed when cells 
were simultaneously treated with GA and trimidox, another inhibitor 
of ribinucleotide reductase.  
 
Faried et al., (2007) reported the anticancer effect of gallic 
acid. Gallic acid, a natural antioxidant isolated from fruits of herbal 
medicinal plant Phaleria macrocarpa. The gallic acid showed 
significant inhibition of cell proliferation in a series of cancer cell 
lines and induces apoptosis in esophageal cancer cells (TE-2), but did 
not show any apoptosis in non cancerous cell (CHEK-1). Gallic acid 
up-regulated the pro-mechanism of apoptosis protein, Bax and 
induced caspase-cascade activity in cancer cell; Gallic acid also down 
regulated anti-apoptosis protein like Bcl-2 and Xiap and induced down 
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regulation of survival Akt/mTOR pathway. In non-cancerous cells, 
gallic acid delayed expression of pro-apoptosis related proteins. 
Gupta et al., (2007) suggested that gallic acid is a potent 
inhibitor of brush border sucrase and other disaccharidases and thus 
could potentially interfere with the digestive functions of the intestine. 
Gallic acid at concentrations of 0.05 to 0.6 mmol/L inhibited sucrase 
activity by 34% to 86% at a pH 4.8 to 7.2.  But at alkaline pH (7.7-
8.5), gallic acid stimulated enzyme activity by 20% to 30% in both rat 
and rabbit intestines. Gallic acid was a fully competitive inhibitor of 
rat sucrase at pH 5.5 and 6.8. Gallic acid showed optimum enzyme 
inhibiting activity at a 0.4-mmol/L concentration, which was 82% in 
the rat, 83% in LACA/L mice, 50% in BALB/c mice, and 28% in 
rabbit intestine. The depressed the activities of maltase (42%), 
trehalase (45%), and lactase (13%) were observed in the rat with gallic 
acid. The gallic acid (0.4 mmol/l) with 4 mmol/l harmaline (-SH 
group–reacting reagents) showed that the observed inhibition was 
additive in nature.  
 
Appeldoorn et al., (2007) reported that gallic acid antagonizes 
p-selectin–mediated platelet–leukocyte interactions. Gallic acid 
potently inhibited the binding of a peptide antagonist (IC50, 7.2 
µmol/l) and biotin-PAA-Lea-SO3H, an established high-affinity 
ligand, to P-selectin (IC50, 85 µmol/l). Gallic acid markedly and dose 
dependently attenuated the rolling of monocytic HL-60 cells over P-
selectin–transfected Chinese hamster ovary cells (EC50, 14.5 µmol/l) 
under dynamic flow condition and increasing the velocity of  
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P-selectin– dependent rolling of human blood leukocytes over a 
platelet monolayer. Gallic acid administration to normolipidemic 
C57/Bl6 and aged atherosclerotic apolipoprotein E–deficient mice 
impaired the baseline rolling of conjugates between activated platelets 
and circulating monocytes over femoral vein endothelium, as judged 
by online video microscopy. 
 
Sener et al., (2007) reported the protective effect of 
rosiglitazone against burn – induced oxidative injury of remote organs 
using rats. Severe burn induces the activation of an inflammatory 
cascade that contributes to the development of subsequent 
immunosuppression, increased susceptibility to sepsis, as well as 
generation of reactive oxygen radicals and lipid peroxidation, leading 
to multiple organ failure. Significant decrease in GSH level, and 
significant increases in malondialdehyde level, myeloperoxidase 
activity and collagen content of tissues observed in severe skin scald 
injury (30% of total body surface area). Similarly, serum aspartate 
aminotransferase, alanine aminotransferase and blood urea 
concentration levels, aswell as lactate dehydrogenase, interleukin-1β 
and tumor necrosis factor-α were elevated in the burn group as 
compared to the control group. Rosiglitazone treatment reversed all 
these biochemical indices. Rosiglitazone possesses anti-inflammatory 
effect that prevents burn-induced damage in remote organs and 
protects against organ damage. 
 
Govindarajan et al., (2006) reported the antiulcer and 
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antimicrobial activity of the 50% aqueous alcoholic extract of the 
Anogeissus latifolia (ALE). The effect of ALE (100 and  
200 mg/kg/b.w.) was studied on aspirin, cold-resistant stress (CRS), 
pylorus ligated (PL) and ethanol-induced ulcers. The level of 
antioxidant enzymes like SOD and catalase along with lipid 
peroxidation was also studied in CRS-induced ulcers. The ALE 
significantly inhibited the formation of ulcers induced by physical and 
chemical agents with a maximum of 84.16% curation (200 mg/kg 
body weight) in CRS-induced ulcers. ALE decreased levels of LPO 
and SOD and increased the catalase activity in CRS-induced ulcers. 
Moderate antibacterial activity and antifungal activity was also 
observed. High performance thin layer chromatography (HPTLC) 
showed the presence of gallic acid and ellagic acid (0.95%, w/w, 
0.25%, w/w, respectively) in the plant.  
 
Bhave et al., (2006) studied the antiulcer effect of amlodipine 
and its interaction with H2 blocker and proton pump inhibitor using 
pylorus ligation in rats. Amlodipine (0.5 mg/kg and 1.0 mg/kg, i.p.), 
famotidine (4.0 mg/kg, i.p.) and omeprazole (4.0 mg/kg, i.p) produced 
significant antiulcer effect which were apparent from the decrease in 
volume of gastric acid secretion and pH, ulcer index and acidity. But 
the lower dose of famotidine (1.0 mg/kg, i.p.), omeprazole (1.0 mg/kg, 
i.p.) and amlodipine (0.25 mg/kg, i.p.) did not show any significant 
effects. Combined administration of amlodipine (0.25 mg/kg, i.p.) plus 
famotidine (1.0 mg/kg, i.p.) and amlodipine (0.25 mg/kg, i.p.) plus 
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omeprazole (1.0 mg/kg, i.p.) showed significant antiulcer effect. 
 
Odabasoglu et al., (2006) investigated the gastroprotective 
effect of usnic acid (UA) isolated from Usnea longissima in 
indomethacin induced gastric ulcers in rats at doses of 25, 50, 100 and 
200 mg/kg body weight. Treatment with indomethacin caused a 
significant decrease in the levels of SOD, GPx and GSH, and an 
increase in the LPO (P<0.05). Administration of all doses of usnic 
acid reversed the trend producing a significant increase of SOD, GSH 
and GPx levels and reduction in LPO level in tissue. UA and 
ranitidine increased the cNOS activity and lowered the iNOS activity 
as compared with indomethacin-treated group. However, CAT, GR 
and MPx activities, increased by indomethacin, were found to be 
lower in the UA and ranitidine-treated groups. The ulcer index also 
significantly decreased in usnic acid and ranitidine treated group. 
 
Kesiova et al., (2006) studied the potential antioxidant activity 
of diphenhydramine (H1 receptor antagonist) and famotidine  
(H2 receptor antagonist). Diphenhydramine inhibited the spontaneous, 
Fe(II)-induced and Fe(II)/ascorbate-induced lipid peroxidation, while 
famotidine showed a biphasic concentration-dependent effect on 
spontaneous lipid peroxidation (a stimulation by 1 mM and an 
inhibition by 5 mM) and increased Fe(II)-induced- and inhibited 
Fe(II)/ascorbate-induced lipid peroxidation in the rat liver and brain. 
Famotidine and diphenhydramine did not alter the catalase activity in 
all tissue preparations, except for its concentration of 5 mM  
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(a complete inhibition). 
  
Kim et al., (2006) investigated the anti-allergic action of gallic 
acid. Immunoglobulin E (IgE) or compound 48/80 -induced histamine 
release from mast cell was attenuated by gallic acid. Modulation of 
cAMP and intracellular calcium is the main mechanism to inhibit the 
histamine release. Gallic acid decreased the phorbol 12-myristate  
13-acetate plus calcium ionophore A23187-stimulated pro-
inflammatory cytokine gene expression and production of TNF-α and 
IL-6 in human mast cells.  Compound 48/80-induced systemic allergic 
reaction and IgE-mediated local allergic reaction was also inhibited by 
gallic acid. Gallic acid inhibits mast cell-derived inflammatory allergic 
reactions by blocking histamine release and pro-inflammatory 
cytokine expression.  
 
Prasad et al., (2006) reported the chemopreventive efficacy of 
gallic acid against ferric nitrilotriacetic acid (Fe-NTA) mediated 
oxidative stress, toxicity and cell proliferative response in Wistar rats. 
The effect of gallic acid against Fe-NTA-induced carcinogen/drug 
metabolizing phase I and phase II enzymes, anti-oxidative parameters, 
kidney markers, tumour promotion markers and lipid peroxidation 
(LPO) in kidney were observed. Significant depletion in the 
detoxification and antioxidant enzyme armoury with concomitar 
elevation in renal LPO, serum creatinine, blood urea nitrogen, 
hydrogen peroxide generation, ornithine decarboxylase activity and 
[3H]thymidine incorporation into renal DNA was observed with 
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intraperitonial administration Fe-NTA (9 mg Fe/kg b.w.). Pretreatment 
with gallic acid (10 and 20 mg/kg b.w.) resulted in a significant 
(P<0.001) decrease in the levels of the parameters measured.  
 
Shinno et al., (2005) investigated the effect of gallic on the rat 
liver microsomal glutathione S-transferase (MGST1) in vitro. When 
microsomes were incubated with gallic acid marked increase in 
MGST1 activity was observed which was prevented in the presence of 
superoxide dismutase or catalase. Decrease in MGST1 activity in 
presence of gallic acid was observed when incubation was done with 
sodium arsenite, a sulfenic acid, reducing agent. The incubation of 
microsomes with gallic acid in the presence of the NADPH generating 
system (which generates ROS) increased the MGST1 activity and 
depressed SOD/CAT. A stable radical, 1,1-diphenyl-2-picrylhydrazyl 
or ferric chloride prevented the increase of MGST1 activity by gallic 
acid. These results suggest that the gallic acid acts as a pro-oxidant 
and activates MGST1 through oxidative modification of the enzyme. 
 
Ahn et al., (2005) studied the antifungal activity of methanolic 
extract of Galla rhois and its active constituents. The biologically 
active constituents like methyl gallate and gallic acid were isolated 
and characterized by spectroscopic analysis. Gallic acid exhibited 
good antifungal activity against Magnaporthe grisea and Erysiphe 
graminis and methyl gallate showed activity against M. grisea, 
Botrytis cinerea and Puccinia recondita. Both of them were 
ineffective against Rhizoctonia solani. Gallic acid moderately or 
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significantly inhibited the conidial germination (64%) and 
appressorium formation (7%) in M. grisea. Methyl galate and gallic 
acid acts on cAMP – related signaling pathway regulating 
appressorium formation in M. grisea. 
 
Aly et al., (2005) examined anti-inflammatory and antiulcer 
activity of licorice. The antiulcer study was done on indomethacin 
induced ulceration model. The decrease in mean ulcerated area and 
percentage of ulceration in the glandular area was observed in licorice 
and famotidine treated animal groups compared to control-
indomethacin group. Antiulcer activity of licorice (100 mg/kg) was 
found similar to that of famotidine (1.14 mg/kg) which used as a 
standard drug. The combination therapy of famotidine (0.57 mg/kg) 
and liqorice (100 mg/kg) showed better anti-ulcer activity than either 
of them alone.   
 
Rukkumani et al., (2004) examined the protective effect of 
curcumin and its analog and its analog on alcohol and thermally 
oxidized sunflower oil (PUFA) induced oxidative stress in Wistar 
albino rats. The liver marker enzymes like glutamyl transferase, 
alkaline phosphatase, lipid peroxidative indices like TBARS, HP and 
antioxidants like vitamin C, vitamin E, GSH, SOD, CAT, GPx were 
estimated. The liver marker enzymes and lipid peroxidative indices 
were investigated significantly in alcohol, PUFA and alcohol + PUFA 
groups. Administration of curcumin and curcumin analog abrogated 
this effect. The antioxidant status which decreased in alcohol, PUFA 
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and alcohol + PUFA groups was effectively modulated by both 
curcumin and curcumin analog treatment.  
 
Anoop and Jegadeesan (2003) studied the antiulcerogenic 
property of aqueous ethanolic extracts of the roots of Hemidesmus 
indicus var. indicus  in different animal models like modified pylorus 
ligated (Shay) rat model and aspirin-induced ulcerogenesis in pylorus 
ligated rats.  The parameters analyzed were gastric volume, ulcer 
score, pH, free and total acidity and sodium and potassium ion output 
and bio-chemical estimations like total proteins, total hexoses, 
hexosamine, fucose, sialic acid and pepsin. Ulcer score was calculated 
for cysteamine-induced duodenal ulcer model. The roots collected 
during flowering and vegetative periods showed antiulcer activities in 
all the parameters studied comparable with that of reference and 
control groups, proving that roots collected during flowering period 
were found to be more effective. 
 
Malairajan et al., (2007) evaluated anti-ulcer activity of the 
ethanol extract of Toona ciliata Roemer (heart wood) against aspirin 
plus pylorus ligation induced gastric ulcer (antisecretory), HCl–
ethanol induced ulcer (cytoprotective) and water immersion stress 
induced ulcer in rats. Toona ciliata extract (300 mg/kg p.o.) markedly 
decreased the incidence of ulcers in all the three models. Significant 
reduction in gastric volume, free acidity, total acidity and ulcer index 
were observed in the rat models which was treated with ethanol 
extract of Toona ciliata. Gastroprotective activity (52.94%) was also 
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observed with the plant extract, whereas standard drug sucralfate 
showed 94.85%. Toona ciliata extract showed protection index 43.0% 
in water immersion stress induced ulcer,whereas standard drug 
omeprazole showed an protection index of 100%. 
 
Yen et al., (2002) investigated the antioxidant and pro-oxidant 
properties of ascorbic acid and gallic acid. The oxidation of 
deoxyribose induced by Fe3+-EDTA-H2O2 was accelerated by gallic 
acid and ascorbic acid at a concentration of 1.65 mM. They showed no 
chelating ability toward iron (II). Ascorbic acid and gallic acid 
exhibited 42.1 and 43.9% scavenging effects on DPPH radicals, 
respectively and exhibited 60% scavenging effects on hydrogen 
peroxide at a concentration of 4.17 mM. Ascorbic acid (0.82 mM) and 
gallic acid (0.6 mM), exhibited the maximal DNA damage. When 
ascorbic acid and gallic acid were mixed with H2O2, a slight inhibitory 
effect on DNA damage was observed. No toxicity was found in 
ascorbic acid and gallic acid toward human lymphocytes. The pro-
oxidant mechanism for both is most likely due to the strong reducing 
power and weak metal chelating ability.  
 
Isuzugawa et al., (2001) proved gallic acid induced apoptosis 
in cancer cell at lower IC50 value compared with the values for normal 
cell.  The addition of conditioned medium from cultured hepatocytes 
results inhibition of apoptosis completely, whereas it is not prevented 
by conditioned media from tumor cells. Gallic acid induced cell death 
mediated by ROS and intracellular Ca2+, and it was found that gallic 
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acid generated hydrogen peroxide in culture medium which induced 
cell death in dRLh-84 cells. Conditioned media from various tumor 
cell lines did not contain catalase, and the cytoplasm contained only 
low levels of catalase. These results show that gallic acid-sensitive 
cells, including various tumor cells have lack of protective machinery 
against gallic acid. 
 
Yesilada et al., (2000) studied the antiulcerogenic activity of 
Spartium junceum L. (Fabaceae) in different experimental animal 
models. The active fraction (saponin fraction) was highly effective in 
preventing ethanol- and pyloric ligation-induced gastric lesions as well 
as in inhibiting gastric secretion volume, gastric pH and titratable 
acidity, but did not affect the hexosamine content of the gastric 
mucosa. Famotidine (20 mg/kg b.w, p.o) was used as a reference 
standard for this study. 
 
Dias et al., (2000) explored antiulcerogenic activity of crude 
hydroalcoholic extract (70%) (CHE) of Rosmarinus officinalis 
employing different experimental models and the CHE decreased the 
ulcerative lesion index produced by indomethacin, ethanol, reserpine 
in rats. No antisecratory activity was observed on pyloric ligation 
model. The hydroalcoholic extract increased mucosal non protein 
sulfhydryl group content and its mechanism has no relationship with 
nitric oxide and prostaglandins.  
 
George et al., (1999) examined the effect of alpha tocopherol 
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on gastric ulcers induced by pylorus ligation. Pre-treatment with 
different dose of alpha tocopherol (400 mg/kg and 600 mg/kg) for 2 
weeks protected the gastric mucosa. Alpha tocopherol significantly 
(P<0.001) decreases ulcer index, gastric juice volume and increases 
pH of gastric juice and mucopolysaccharide contents in dose 
dependent manner. Vitamin E decreased the gastric ulcer and this 
effect may be mediated through its antioxidant effect.  
 
Singh and Majumdar (1999) performed antiulcer activity of 
Ocimum sanctum L. (Labiatae) against aspirin, indomethacin, 
histamine, alcohol, reserpine, serotonin and stress induced ulceration 
in experimental animal models. Ulcer index was found to decrease 
significantly for Ocimum sanctum (fixed oil) in all the animal models 
in a dose dependent manner. The inhibitions of gastric secretion, total 
acidity were observed in aspirin plus pylorus ligated rats. This 
suggests that Ocimum sanctum fixed oil can be considered to be a drug 
of natural origin. 
 
Venkataranganna et al., (1998) investigated the antiulcer 
activity of UL-409 (a herbal preparation) and its mechanism of action 
on different experimental models. UL-409 (600 mg/kg, p.o.) 
significantly reduced the gastric secretion, total acidity, free acidity 
and increased carbohydrate:protein ratio which is the gastric mucosal 
defense mechanism in aspirin + pylorus ligated rats. Pretreatment with 
UL-409 showed inhibition of alcohol induced contraction of isolated 
  56
rat fundus preparation which was reversed by indomethacin proving 
involvement of cyclo-oxygenase system. 
 
Yesilada et al., (1997) evaluated the antiulcer effect of the 
flower and flower buds of Cistus laurifolius L. The aqueous extract 
showed good antiulcer activity on pylorus ligation, absolute ethanol, 
indomethacin, indomethacin plus HCl/EtOH induced gastric and 
cysteamine induced duodenal ulcer model in rats and mice. The 
parameters like ulcer index, gastric juice secretion and pH, titrable 
acidity and acid output, peptic activity and hexosamine content 
determination was performed. The active fraction showed a potent 
anti-acid activity. 
 
Inoue et al., (1994) found that gallic acid can induce cell death 
in promyelocytic leukemia HL-60RG cells. Flow cytometric analysis 
reversed that the apoptosis was not triggered at a specific phase of the 
cell cycle and 2 h exposure of gallic acid to HL-60RG cells was 
enough to induce apoptosis. The gallic acid -induced cell death was 
mediated by ROS such as hydrogen peroxide, superoxide anion in 
addition to Ca2+ ion, calmodulin-dependent enzymes. 
 
Nakayama et al., (1993) investigated the effects of gallic acid 
and its esters on H2O2-induced cytotoxicity, mutagenicity and SOS 
response in bacterial assay systems, i.e., the Ames test with 
Salmonella typhimurium TA104 and the SOS chromotest with E. coli 
PQ37. Gallic acid esters found to have the protective effects against 
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H2O2-induced cytotoxicity and no effects on the number of revertant 
colonies and lowered the SOS induction factor raised by H2O2 in 
Ames and SOS chromo test respectively.  
 
Dorsch et al., (1992) investigated the anti-asthmatic effects of 
Galphimia glauca, gallic acid, and related compounds. The platelet-
activating factor (PAF) induced bronchial hypersensitivity was 
markedly reduced. Gallic acid, methyl gallate and quercetin showed 
significant effects after a single oral dose of 45 mg/kg, tetragalloyl 
quinic acid after 5 mg/kg. Continuous treatment of the animals with 
one certain fraction (GG II, 3 days, 3 x 2 mg/kg) containing all active 
compounds reduced allergen- and PAF-induced bronchial reactions by 
more than 70%. 
 
Mukhopadhyaya et al., (1987) showed the anti-ulcerogenic 
effects of banana pulp powder on aspirin induced gastric and 
cysteamine induced duodenal ulceration in rats. Banana treated  
(0.5 g/kg twice daily for 3 days) rats showed significant decrease in 
gastric juice DNA and protein, increase in total carbohydrate and 
carbohydrate/protein ratio of gastric juice. In aspirin treated rats 
opposite effect was observed. The increase in [3H] thymidine 
incorporation into mucosal cell DNA was found in both the cases. The 
results tend to confirm that plantain banana powder strengthens 
mucosal resistance and promotes the healing of ulcers. 
 
  58
Bank et al., (1985) studied the synergistic effect of the 
combination of ranitidine and sucralphate in prevention of duodenal 
ulcer. Duodenal ulcers were induced in rats with the secretagogues 
pentagastrin and bethanechol. Subtherapeutic doses of ranitidine (5 
mg/kg/6 h) and sucralphate (50 mg/6 h) yielded an ulcer index which 
was not significantly different from the control (untreated) ulcer index 
of 4.3. But ulcer index (0.4 and 0.5) decreased significantly at a 
therapeutic dose of ranitidine (20 mg/kg) and sucralphate (200 
mg/animal). When sub therapeutic doses of ranitidine and sucralphate 
given in combination the ulcer index reduced significantly at 0.7. The 
study thus showed sub therapeutic doses of ranitidine and sucralphate 
given in combination had a synergistic effect equal to therapeutic 
doses of each of these drugs given alone. 
 
Osborne et al., (1981) showed that gallic acid reduced the 
antiviral activity of human beta interferon. Cell cultures were 
incubated with mixtures of either GA and beta interferon (IFN-β) or 
medium and IFN-β. The cells were subsequently challenged with 
virus. The virus plaque yields were greater in cells incubated with 
IFN-β and gallic acid than in cells incubated with IFN-β and medium, 
indicating that IFN-β had lost antiviral activity in former mixture. The 
effect of gallic on IFN-β could be reversed with 2-mercaptoethanol 
due to possible sulfhydryl involvement. The removal of gallic acid 
from IFN-β by dialysis failed to reverse the reduction in antiviral 
activity. This suggests that reduction of the activity of IFN-β due to 
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irreversible interaction between IFN-β and gallic acid.  
 
Niebes (1972) determined the enzyme and its  
degradation products of glycosaminoglycan metabolism  
in the serum of healthy and varicose subjects. The activity  
of 3-glycosaminoglycan hydrolases (β-lucuronidase,  
β-N-acetylglucosaminidase and arylsulfatase) and glycosaminoglycan 
and glycoprotein components were significantly increased in varicose 
patient compared to healthy subjects.  The various parameters like 
determination of sialic acid, total hexoses, fucose, hexosamines, 
sulphate and total non protein polysaccharides were measured to 
estimate the mucopolysaccharide components. 
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3. OBJECTIVE AND PLAN OF WORK 
 Peptic ulcer is a chronic disease that has become a common 
health problem affecting a large number of people world wide causing 
morbidity and mortality. The pathophysiology of this gastro-intestinal 
disorder is viewed as an imbalance between mucosal defensive factors 
such as bicarbonate, prostaglandin, nitric oxide, peptides, growth 
factors and injurious factors like acid, pepsin. Reactive oxygen species 
(ROS) plays an important role in the pathogenesis of various clinical 
disorders and gastric damage imposed by physical, chemical and 
psychological factors contribute to gastric ulceration in humans and 
animals. Different class of drugs are currently used in the treatment of 
peptic ulcer like H2 blockers (famotidine, ranitidine), proton pump 
inhibitors (omeprazole), M1 blockers (pirenzepine), protective agents 
of mucosal barrier (sucralfate) and cytoprotective drugs (misoprostol).  
Although a wide range of drugs are currently employed in the 
management of ulcer, most of them exhibit side effects like 
arrhythmias, impotence, gynaecomastia, artralgia, hypergastrinemia 
and haemopoeitic changes. Alternative approach in recent days is the 
research of medicaments from ayurvedic or traditional medicinal 
system. The use of phyto-constituents as drug therapy to treat major 
ailments has proved to be clinically effective and less relatively toxic 
than the existing drugs and also reduces the offensive factors serving 
as a tool in the prevention of peptic ulcer.  
 Gallic acid (3,4,5- trihydroxy benzoic acid) is a naturally 
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abundant plant phenolic compound found in grapes, green tea,  
pineapple, bananas, lemon, straw berries etc. and possess excellent 
antioxidant, anti-obesity, hepatoprotective, anti-inflammatory, 
antimicrobial, anti allergic, antifungal, antiasthmatic, chemoprotective 
and anticancer activity.  
 Drugs or formulations that possess potent anti-oxidant actions 
can be more effective in healing experimentally induced gastric ulcers. 
The multiple effects possessed by gallic acid made us to investigate 
the antiulcer activity. The objective of our study is to evaluate the 
antiulcer activity of gallic acid alone and in combination with a known 
antiulcer agent famotidine using aspirin plus pyloric ligation induced 
gastric ulcer model in rats. 
PLAN OF WORK 
¾ To evaluate the antiulcer activity of gallic acid alone and in 
combination with famotidine using aspirin plus pyloric ligation 
induced gastric ulcer model in rats. 
¾ To determine the ulcer index, percentage inhibition, gastric 
volume and pH of gastric juice. 
¾ Estimation of total and free acidity, peptic activity, total protein 
and individual carbohydrates like hexoses, hexosamine, fucoses 
concentration in gastric juice. 
¾ To determine the antioxidant property of the drug by estimation 
of SOD, CAT, GSH, GR, GPx, TBARS, HP, MPx and glucose 
6-phosphate dehydrogenase (G6PD) levels in stomach and liver 
tissue homogenates. 
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¾ Histopathological evaluation of the stomach. 
¾ Statistical analysis using ANOVA followed by Dunnett’s test. 
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4. MATERIALS AND METHODS 
4.1  DRUGS & CHEMICALS 
 Aspirin and famotidine were obtained from Shasan 
Pharmaceuticals. Gallic acid and bovine serum albumin and were 
purchased from Loba Chemie Pvt Ltd (Mumbai). Calf thymus DNA 
was purchased from Sigma Aldrich (USA), Orcinol, D(+) 
glucosamine hydrochloride, cysteine reagent, O-dianisidine 
hydrochloride and reduced glutathione were procured from Himedia 
Laboratories Pvt Ltd (Mumbai). Thiobarbituric acid, trichloro acetic 
acid, fucose, oxidized glutathione, epinephrine and 5, 5- dithiobis (2-
nitro benzoic acid) were obtained from Sisco Research Laboratories 
Pvt. Ltd. (SRL), Mumbai. All other chemicals used in the study were 
obtained commercially and were of analytical grade.     
4.2  EXPERIMENTAL ANIMALS 
 Wistar albino rats of either sex weighing between 150-250 g 
were used. They were maintained under standard laboratory 
conditions at a temperature of 23 ± 2ºC, with 12 h light - dark cycle, 
and relative humidity (50 ± 10%). The animals were fed with standard 
food pellets (Hindustan Lever Ltd) and water ad libitum. The rats were 
deprived of food for 18 h with free excess of water before the 
experimental procedure. All animal procedures have been approved by 
Ethical Committee in accordance with animal experimentation and 
care bearing the number 817/04/AC/CPCSEA. 
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4.3  ANTIULCER ACTIVITY 
Aspirin plus pylorus ligation induced ulcer 
  The rats were divided into 13 groups (n=6). Gallic acid, aspirin 
and standard antiulcer drug famotidine were prepared in 0.5% carboxy 
methyl cellulose suspension as vehicle and administered orally once 
daily at a volume of 10 ml/kg b.w. for 7 days using oral gavage 
needle. Group I was administered with 0.5% CMC and served as 
untreated control. Group II received aspirin alone (200 mg/kg b.w.) 
and served as ulcer control group, Group III was treated with test drug 
gallic acid (200 mg/kg, b.w.). Group IV received famotidine (20 
mg/kg, b.w.) and served as standard. Group V – VII received gallic 
acid 200 mg/kg b.w. in combination with 5, 10, 20 mg/kg famotidine 
respectively. Group VIII - X were administered with gallic acid  
100 mg/kg b.w. in combination with 5, 10, 20 mg/kg famotidine 
respectively. Gallic acid 50 mg/kg b.w. in combination with 5, 10, 20 
mg/kg famotidine was administered to group XI – XIII respectively.  
From days 5 to 7, animals in group II - XIII received aspirin at a 
dose of 200 mg/kg, 2 h after the administration of respective drug 
treatment. Animals in all groups were fasted for 18 h after the 
assigned drug treatment and were anesthetised with anesthetic ether. 
The abdomen was cut opened by a small midline incision below the 
xiphoid process and pylorus portion of stomach was lifted out and 
ligated. Precaution was taken to avoid traction to the blood supply. 
The stomach was sutured and replaced carefully and the abdomen wall 
closed in two layers with interrupter sutures. The animals were 
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deprived of water during post operative period. After, 4 h of pylorus 
ligation the rats were sacrificed and the stomach was removed and 
examined and contents were collected for biochemical estimation 
(Umamaheswari et al., 2007, Sairam et al., 2002). 
4.4  BIOCHEMICAL PARAMETERS 
  The stomach was carefully excised keeping oesophagus closed 
and opened along the greater curvature and luminal contents were 
removed. The gastric contents were collected in a test tube and 
centrifuged. The samples were analyzed for gastric juice volume, pH, 
free and total acidity. Biochemical estimations like total protein, 
hexoses, hexosamine, fucose, DNA and pepsin were performed.  
4.4.1  Measurement of gastric juice volume and pH  
 Gastric juice was collected from aspirin plus pylorus ligation 
induced ulcer rats. The gastric juice thus collected was centrifuged at 
3000 rpm for 10 min. The volume of supernatant was measured and 
expressed as ml/100 g body weight. The pH of the supernatant was 
measured using digital pH meter (George et al., 1999). 
4.4.2 Determination of free and total acidity 
 An aliquot of 1.0 ml of gastric juice was pipetted out into a  
50.0 ml conical flask and 2/3 drops of Topfer’s reagent was added to it 
and titrated with 0.01 N NaOH until all traces of the red colour 
disappeared and the colour of the solution turned yellowish orange. 
The volume of 0.01 N NaOH noted. The volume corresponds to free 
acidity. Then 2/3 drops of phenolphthalein reagent was added and 
titration was continued until a permanent pink color was developed. 
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The volume of total alkali consumed was noted which corresponds to 
total acidity. The free acidity and total acidity was determined using 
the formula and values are expressed as meq/l per 100 g. (Anoop and 
Jegadeesan, 2003). 
 
Acidity =
Volume of NaOH   X   Normality of NaOH   X   100
0.1
(meq/l per 100 g)
 
4.4.3  Estimation of total protein 
 The dissolved protein present was estimated by treating gastric 
juice with 90% alcohol (1:9). An aliquot of  0.1 ml of alcoholic 
precipitate of gastric juice was taken and dissolved in 1.0 ml of 0.1 N 
NaOH. From this 0.05 ml was taken in another test tube and 4.0 ml of 
alkaline copper solution was added and allowed to stand for 10 min. 
Then, 0.4 ml of phenol reagent was added very rapidly and mixed 
quickly and incubated in room temperature for 30 min for color 
development. Reading was taken against blank prepared with distilled 
water at 610 nm in UV – visible spectrophotometer. The protein 
content was calculated from standard curve prepared with bovine 
serum albumin and expressed in terms of µg/ml of gastric juice 
(Lowry et al., 1951). 
4.4.4  Measurement of pepsin            
 For each determination four tubes, 1 and 2 containing 5.0 ml of 
substrate (0.5% BSA), 3 and 4 containing 10.0 ml of trichloro acetic 
acid (TCA) was placed in the water bath at 37ºC. The gastric juice was 
mixed with an equal volume of HCl (1:1) at pH 2.1, warmed to 37ºC 
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and added 1.0 ml of mixture to each tubes 1 and 4, incubated for 15 
min and at the end, mixed the contents of tube 1 with tube 3 and 
allowed to stand in the bath for about 4 min. Contents of tube 1 and 
tube 3 gives test and contents of tube 2 and tube 4 gives blank. Both 
the contents were filtered after 25-30 min, 2.0 ml of filtrate was 
pippeted into 10.0 ml of NaOH, mixed by gentle rotation, then 1.0 ml 
of phenol was added and again mixed by gentle rotation. After 30 min, 
the intensity of colour was measured at 680 nm in a 
spectrophotometer. The difference between test and blank gives a 
measure of peptic activity. As standard, mixed 2.0 ml of freshly 
prepared phenol solution containing 50 mg/ml with 10 ml of NaOH 
and 1.0 ml of phenol reagent was added. After 5-10 min, the colour 
intensity was measured at 680 nm (Debnath et al., 1974). 
4.4.5  Estimation of total carbohydrate content  
 To 1.0 ml of gastric juice, 9.0 ml of 90% ethanol was added 
(1:9). The mixture was kept for 10 min and the resultant solution was 
centrifuged and supernatant was discarded. The precipitate thus 
obtained was dissolved in 0.5 ml of 0.1 N NaOH. To this, 1.8 ml of  
6 N HCl was added. The mixture was hydrolyzed in water bath at 
100ºC for 2 h. The hydrolysate thus obtained was neutralized with 5 N 
NaOH using phenolphthalein as indicator and the volume was made 
up to 4.5 ml with distilled water and used for the estimation of total 
hexoses, hexosamine and fucose (Goel et al., 1985). 
Hexoses  
 To 0.4 ml of hydrolysate, 8.5 ml of orcinol reagent was added 
  68
by keeping test tube in ice-bath. The mixture was then heated in the 
boiling water bath at 80ºC for 15 min. It was then cooled under tap 
water and allowed the color to develop in the dark. The intensity of the 
color was measured after 25 min at 540 nm against the blank by using 
distilled water instead of hydrolysate. Total hexoses content was 
determined from the standard curve of D(+) – galactose – mannose 
(equal quantities of galactose and mannose in 1.0 ml water) and 
expressed in µg/ml of gastric juice (Neibes, 1972). 
Hexosamine 
 About 0.5 ml of the hydrolysate fraction was taken in a test 
tube. To this, 0.5 ml of acetyl-acetone reagent was added. The mixture 
was heated in water bath at 60ºC for 20 min and then cooled under tap 
water. To this, 1.5 ml of 90% alcohol was added and allowed for  
30 min. The color intensity was measured in a UV – visible 
spectrophotometer at 530 nm against blank prepared by using distilled 
water instead of hydrolysate. Hexosamine content was determined 
from the standard curve prepared by using D(+) glucosamine 
hydrochloride and concentration has been expressed in µg/ml of 
gastric juice (Anoop and Jegadeesan, 2003). 
Fucose  
 Three test tubes were taken and in one tube 0.4 ml of distilled 
water was added which served as control (blank).  In each of the other 
two tubes 0.4 ml of hydrolysates were taken. Then 1.8 ml of sulphuric 
acid: water (6:1) was added in all the test tubes by keeping the test 
tubes in ice-cold water bath to prevent breakage due to strong 
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exothermic reaction. The tubes containing the mixture were then 
heated in boiling water bath for exactly 3 min and cooled. Then,  
0.1 ml of cysteine reagent (3% cysteine hydrochloride in water) was 
added to the blank and to one of the hydrolysate containing tube 
(unknown) and cysteine reagent was not added to the last tube 
containing the hydrolysate (unknown blank). It is then allowed for  
90 min to complete the reaction. The absorbance was taken in a UV- 
visible spectrophotometer at 396 and 430 nm setting zero with 
distilled water. The optical density for the fucose in the hydrolysate 
was calculated from the differences in the reading obtained at 396 and 
430 nm and subtracting the values without cysteine. This was read 
against standard curve prepared with D(+)-fucose. The fucose content 
was expressed in terms of µg/ml of gastric juice (Anoop and 
Jegadeesan, 2003). 
True optical density  =
(OD396
_OD430)
unknown _ (OD396
_OD430)
unknown blank
(OD396
_OD430)
water blank
 
4.4.6  Estimation of DNA 
  An aliquot of 1.0 ml of gastric juice were added to 0.05 ml of 
0.2 M EDTA, 0.1 ml of 3% albumin and 0.1 ml of 50% TCA. The 
samples were kept frozen for 48 h and then thawed at 37ºC and 
centrifuged at 2000 rpm for 30 min at 4ºC. The precipitate was taken 
and washed with 5.0 ml of 5% TCA and then centrifuged. To the 
precipitate was added 2.0 ml of 5% TCA with constant stirring. The 
resultant solution was taken in glass stoppered tubes and heated for  
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15 min at 90ºC in a boiling water bath. The solution was again 
centrifuged and the precipitate was treated with TCA and similarly 
hydrolysed and centrifuged. The supernatant after the two hydrolyses 
were pooled together and the volume noted. 
 Briefly, 2.0 ml of hydrolysate was taken into a glass stoppered 
tube containing 0.2 ml of 60% (w/v) perchloric acid. To this, 2.0 ml of 
2% diphenylamine reagent was added and then the tube was kept in 
refrigerator (6-10ºC) for 48 h and the absorbance was read at 600 nm 
using the blank prepared with 2.0 ml of 5% TCA instead of 
hydrolysate. The concentration of DNA was determined from a 
standard curve prepared earlier with calf thymus DNA and expressed 
as µg/ml of gastric juice/100 g body weight of animal 
(Mukhopadhyaya et al., 1987). 
4.4.7 Ulcer index (UI) 
 The mucosa was flushed with saline and stomach pinned on a 
frog board. The lesion in glandular portion examined under a  
10x magnifying glass and length was measured using a divider and 
scale and gastric ulcer was scored. Ulcer index of each animal was 
calculated by adding the following values and their mean values 
determined (Dias et al., 2000). 
(i)  Loss of normal morphology    -  1 point 
(ii) Discoloration of mucosa           -  1 point 
(iii) Mucosal edema                      -  1 point 
(iv) Haemorrhages                        -  1 point 
(v) Petechial point (until 9)         -  2 point 
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(vi) Petechial point (> 10)          -  3 point 
(vii) Ulcer upto 1 mm                   - n × 2 point 
(viii) Ulcer > 1 mm                        - n × 3 point 
(ix) Perforated ulcer                  - n × 4 point 
          Where, ‘n’ is the number of ulcer found. 
4.4.8  Percentage inhibition  
 Percentage inhibition was calculated using the following 
formula (Malairajan et al., 2007) 
%  Inhibition  =
UI ulcer control
_ UI treated
UI ulcer control
100×
 
4.5  BIOCHEMICAL INVESTIGATION OF  STOMACH AND 
LIVER TISSUE      
4.5.1  Preparation of stomach mucosa homogenate 
 The stomach was opened and washed with 0.15 M KCl after the 
microscopic examination. The mucosa was scraped from the glandular 
part of stomach, suspended in 5.0 ml of cooled 0.15 M KCl-10 mM 
potassium phosphate buffer (pH 7.4) containing 0.1% Triton X-100 
and centrifuged at 1000 × g for 10 min (Kesiova et al., 2006). 
4.5.2 Preparation of liver homogenate 
 The liver was perfused with cooled 0.15 M KCl. The 10% 
homogenate in 0.15 M KCl-10 mM potassium phosphate buffer, pH 
7.4 was centrifuged at 3000 rpm for 10 min (Kesiova et al., 2006). 
4.5.3  Estimation of superoxide dismutase (SOD) 
 SOD activity was determined by the inhibition of autocatalyzed 
adrenochrome formation in the presence of tissue homogenate at  
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480 nm. The reaction mixture contained 150 µl of homogenate, 1.8 ml 
of 30 mM carbonate buffer (pH, 10.2), and 0.7 ml of distilled water 
and 400 µl of epinephrine (45 mM).  Auto oxidation of epinephrine to 
adrenochrome was performed in a control tube without the 
homogenate. The activity was expressed as units/mg tissue protein 
(Misra and Fridovich, 1972).   
4.5.4 Estimation of catalase (CAT) 
 The catalysis of H2O2 to H2O in an incubation mixture adjusted 
to pH 7.0 was recorded at 254 nm.  The reaction mixture contained 2.6 
ml of 25 mM potassium phosphate buffer pH 7.0 and 0.1 ml of tissue 
homogenate and was incubated at 37ºC for 15 min and the reaction 
was started with the addition of 0.1 ml of 10 mM H2O2.  The time 
required for the decrease in absorbance from 0.45 to 0.4 representing 
the linear portion of the curve was used for the calculation of enzymic 
activity.  One unit of catalase activity was defined as the amount of 
enzymes causing the decomposition of µM H2O2/mg protein/min at 
pH, 7.0 at 25ºC (Aebi, 1984). 
4.5.5 Estimation of glutathione reductase (GR) 
 The reaction mixture contains 2.1 ml of  0.25 mM potassium 
phosphate buffer pH 7.6, 0.1 ml of 0.001 M NADPH, 0.2 ml of 0.0165 
M oxidized glutathione, 0.1 ml of BSA (10 mg/ml).  The reaction was 
started by the addition of 0.2 ml of tissue homogenate with mixing and 
the decrease in the absorbance at 340 nm was measured for 3 minutes 
against a blank. Glutathione reductase activity was expressed as µM 
NADPH oxidized/min/mg protein at 30ºC (Racker, 1955). 
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4.5.6 Estimation of reduced glutathione (GSH) 
 The method was based on the reaction of reduced glutathione 
with dithionitrobenzoic acid (DTNB) to give a compound that absorbs 
at 412 nm. Briefly after centrifugation, 0.5 ml of supernatant was 
taken and mixed with 2.0 ml of 0.3 mol/l di-sodium hydrogen 
phosphate (Na2HPO4) solution. A 0.2 ml solution of 
dithiobisnitrobenzoate (0.4 mg/ml, 1% sodium citrate) was added and 
the absorbance was measured immediately after mixing at 412 nm. 
Results were expressed in µM GSH/min/mg protein. (Sener et al., 
2007).  
4.5.7 Estimation of glutathione peroxidase (GPx) 
 The reduction of GSSG is coupled to the oxidation of NADPH 
through glutathione reductase. The reaction mixture contained 100 µl 
tissue homogenate solution  and  800 µl 100 mM/l potassium 
phosphate buffer (pH 7.4), containing 1 mM/l EDTA, 1 mM/l sodium 
azide, 0.2 mM/l NADPH, 1 U/ml glutathione reductase and  
1 mM/l GSH.  After 5 min the reaction was started by the addition of 
100 µl 2.6 mM hydrogen peroxide and the absorbance change at  
340 nm in 3 min was recorded at 37ºC. Various controls were carried 
out and suitably subtracted. Glutathione peroxidase activity was 
expressed as µM NADPH oxidized /min /mg protein at 37ºC (Hsu and 
Yen, 2007). 
4.5.8 Estimation of lipid peroxidative indices 
Measurement of thiobarbituric acid reactive substances (TBARS) 
 For TBARS, 0.1 ml of tissue homogenate (Tris-HCl buffer, pH 
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7.5) was mixed with 2.0 ml of TBA-TCA-HCl reagent (thiobarbituric 
acid 0.37%, 0.25 N HCl and 15% TCA mixed in 1:1:1 ratio). The 
resultant solution was placed in water bath for 15 min, cooled and 
centrifuged at 1000 rpm for 10 min. The absorbance of clear 
supernatant was measured against reference blank at 535 nm. The 
results were expressed as nM/min/mg tissue protein (Rukkumani  
et al., 2004). 
 
Measurement of hydroperoxides (HP) 
 For HP, about 0.1 ml of tissue homogenate was treated with  
0.9 ml of Fox reagent (88 mg butylated hydroxytoluene (BHT),  
7.6 mg xylenol orange and 9.8 mg ammonium ion sulphate  were 
added to 90.0 ml of methanol and 10.0 ml 250 mM sulphuric acid) and 
incubated at 25ºC for 30 min. The color developed was read at  
560 nm spectrophotometrically. The values were expressed as 
nM/min/mg of protein (Rukkumani et al., 2004).   
4.5.9 Estimation of myeloperoxidase (MPx) activity 
 A 100.0 µl of the homogenate was added to 1.9 ml of 10 mM/l 
phosphate buffer (pH 6.0) and 1.0 ml of 1.5 mM/l O-dianisidine 
hydrochloride containing 0.0005% (w/v) hydrogen peroxide. The 
changes in absorbance at 450 nm of each sample were recorded on a 
UV–visible spectrophotometer. MPx activities in tissues were 
expressed as µM /min /mg protein (Odabasoglu et al., 2006). 
4.5.10 Estimation of glucose 6-phosphate dehydrogenase (G6PD) 
 G6PD was assayed by measuring the increase in absorbance 
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which occurs at 340 nm due to NADP being reduced to NADPH. This 
reaction takes place when two electrons were transferred from 
glucose-6- phosphate to NADP catalyzed by the enzyme G6PD in the 
reaction. 
 The reaction mixture consists of 2.0 ml of 0.1 M of Tris-HCl 
buffer (pH 8.2), 0.1 ml of 0.2 mM NADP, 3.0 ml of MgCl2, 0.4 ml of 
H2O and 0.1 ml of enzyme solution. The reaction was started by the 
addition of 0.1 ml of 6 mM glucose - 6 - phosphate and the increase in 
absorbance was measured at 340 nm. The activity was expressed in 
terms of µM /min /mg protein (Sudnikovich et al., 1963). 
4.6  HISTOPATHOLOGY  
 Stomachs were immersed in 10% formalin for 24 h for 
histopathological examination. The central part of the damaged or 
ulcerated tissue if present was cut in half along the long diameter. In 
case of whole stomach protected from the ulcer, then any section was 
taken from basal part. After processing,   the tissue was embedded in 
paraffin and cut into 5 µm thick sections. The sections were stained 
with haematoxylin-eosin for histopathological examination (Yesilada 
et al., 1997).  
4.7  STATISTICAL ANALYSIS 
 Values are expressed as mean ± standard error mean (S.E.M) 
and analyzed using statistical package for social science (SPSS) 
version 10.0 using ANOVA followed by Dunnett’s test.  
P<0.05 were considered statistically significant. 
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5. RESULTS 
 In the present study antiulcerogenic activity of gallic acid alone 
and in combination with famotidine was evaluated using aspirin plus 
pylorus ligation induced ulcer model. Aspirin plus pylorus ligation 
induced animals showed extensive gastric lesions that were confined 
to the glandular portion of the stomach which is evidenced by an 
increase in ulcer index when compared with untreated control  
(P<0.01) (Table 1). The higher dose combinations like GA 200 + FM 
10 and GA 200 + FM 20 exhibited a marked reduction in ulcer which 
is evidenced by reduction in ulcer index and an increase in percentage 
of inhibition. Combination of GA 100 + FM 10 and GA 100 + FM 20 
resulted in a similar decrease in ulcer index and increase of percentage 
inhibition and the ulcer healing effect was found to be better than the 
individual agents when administered alone and the result was found to 
be statistically significant with P<0.01. Combinations of  
GA 200 + FM 5 and GA 50 + FM 20 also produced effects greater 
than their individual effects. However, lower dose combinations 
resulted in a decrease of ulcer protection effects when compared to 
higher dose combinations and was found to be lesser than the 
individual agents administered alone (Table 1). 
 Table 1 shows significant increase in gastric juice volume and 
decrease in gastric pH in ulcer control rats when compared to control 
which received vehicle alone. Oral treatments with various 
combinations of gallic acid and famotidine for 7 days lead to 
significant (P<0.01) decrease of gastric juice volume when compared 
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to individual treatment. Gastric pH was also elevated among the 
combination treatment and the increase in pH was greater than their 
individual administration showing the acid neutralization capacity of 
the test compounds. Almost all the combinations raised the pH above 
3.0 and the results were statistically significant (P<0.01). However, 
GA 50 + FM 5 coadministration did not significantly improve the  
pH (1.58) on comparison with ulcer control which had pH of 1.17. 
 Significant increase in total and free acidity, pepsin content, 
DNA content and total protein concentration was observed in ulcer 
control rats when compared to control. The levels of total and free 
acidity, pepsin activity and DNA concentration in the gastric juice of 
animals which received varying dose of GA + FM was found to 
decrease dramatically proving the efficacy of combination treatment. 
This decrease was significantly higher (P<0.01) than the values 
obtained upon individual administration of gallic acid and famotidine 
(Table 2). 
 The individual carbohydrate contents like total hexoses, 
hexosamine and fucose concentration was also decreased in ulcer 
control rats significantly (P<0.01) when compared to normal untreated 
rats. Pretreatment with gallic acid and famotidine for 7 days showed 
an pronounced decrease in total protein content of gastric juice when 
compared against ulcer control. Among the combinations  
GA 200 + FM 10, GA 200 + FM 20, GA 100 + FM 20 and  
GA 50 + FM 20 exhibited better reduction in protein content (Table 
3). All the drug combination significantly (P<0.01) increased the 
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individual carbohydrate like hexoses, hexosamine and fucose 
indicating the increase in glycoprotein content when compared to 
ulcer control. However, the combination of GA 50 + FM 5 did not 
produce any significant increase in hexoses and hexosamine content 
(Table 3). 
 Table 4 shows the level of antioxidant enzymes in the stomach 
homogenates of animals treated with gallic acid, famotidine and 
different combinations of both agents at varying dose levels. A 
significant decrease (P<0.01) in the levels of enzymatic and non-
enzymatic antioxidant enzymes like SOD, CAT, GSH, GPx, GR and 
G6PD were observed in ulcer control animals on comparison with 
control untreated animals. Administration of gallic acid, famotidine 
alone and in suitable combinations tends to attenuate the levels of all 
antioxidant enzymes justifying the protection offered by them in 
conditions of gastric damage. The results obtained were found to be 
statistically significant (P<0.01) with higher protection rate as 
compared to their individual treatments. The levels MDA and HP, the 
end product of lipid peroxidation parameters were significantly 
(P<0.01) elevated in the ulcerative stomach homogenate (Table 5). A 
similar increment in level of MPx was also observed in ulcer control. 
These high levels of MDA, HP and MPx were profoundly reduced 
(P<0.01) among all the high and lower dose combination groups when 
compared to the animals which received only gallic acid and 
famotidine. 
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 The antioxidant enzyme activity was also investigated using the 
liver tissue in order to check the oxidative stress in liver during gastric 
ulcer. The results obtained by the effect of the drugs on different 
antioxidant parameters are tabulated in Table 6 and 7. The ulcer 
control group showed significant (P<0.01) depletion in the levels of 
SOD, CAT, GSH, GR, GPx and G6PD and increase in MDA, HP and 
MPx, depicting the oxidative stress in liver during gastric ulcer. 
Pretreatment with gallic acid, famotidine and all the combinations 
showed significant (P<0.01)  increase in levels of SOD, CAT, GSH, 
GR, GPx and G6PD and decrease in MDA, HP and MPx levels 
proving the protective nature of test compound. 
 Microscopic observation of control rats showed normal 
appearance of gastric mucosa (Fig. 7). Ulcer control animals (Fig. 8a) 
showed ulcer crater with distorted gastric glands and damaged 
mucosal epithelium, with inflammation and congestion in the wall of 
ulcerated stomach. Protection against these histopathological changes 
was observed by apparent epithelializations, glandular organization, 
maintenance of mucosa and reduced ulcer size in drug treated groups. 
The histopathological picture of famotidine and gallic acid showed 
less inflamed tissue with no ulceration (Fig. 8b, 8c). Combinations 
like GA 200 + FM 10, GA 200 + FM 20, GA 100 + FM 20 also 
showed no ulceration. The other combinations were also found to be 
effective with mild inflammation in tissue and no ulceration. 
  80
Table 1: Effect of gallic acid and its combinations on gastric 
parameters in aspirin plus pylorus ligation induced ulcer rats 
Group Ulcer Index Percentage 
Inhibition 
(%) 
Volume of 
gastric 
juice 
(ml/100g) 
pH         
of gastric 
juice 
Control 0.00 ± 00 - 0.66 ± 0.06 2.00 ± 0.06
Ulcer Control 32.33 ± 2.33 
b 
– 4.81 ± 0.54 
b 
1.17 ± 0.17 
b 
GA (200 
mg/kg) 
7.81 ± 1.28 b 75.84 2.50 ± 0.10 
a 
2.32 ± 0.16 
b 
FM (20 mg/kg) 5.83 ± 0.47 b 81.97 2.24 ± 0.12 
b 
2.48 ± 0.07 
b 
GA 200 + FM 
5 
5.80 ± 1.07 b 82.03 2.33 ± 0.10 
a 
3.11 ± 0.09 
b 
GA 200 + FM 
10 
3.33 ± 0.42 b 89.70 1.84 ± 0.07 
b 
3.23 ± 0.06 
b 
GA 200 + FM 
20 
2.33 ± 0.42 b 92.79 1.61 ± 0.06 
b 
3.45 ± 0.09 
b 
GA 100 + FM 
5 
8.50 ± 0.76 b 73.71 2.40 ± 0.07 
a 
2.87 ± 0.07 
b 
GA 100 + FM 
10 
4.66 ± 0.61 b 85.59 2.02 ± 0.09 
b 
3.11 ± 0.10 
b 
GA 100 + FM 
20 
2.66 ± 0.30 b 91.77 1.73 ± 0.08 
a 
3.29 ± 0.11 
b 
GA 50 + FM 5 13.00 ± 0.89 59.78 3.15 ± 1.58 ± 0.10 
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a 0.17a c 
GA 50 + FM 
10 
9.72 ± 0.42 b 69.93 2.11 ± 0.08 
b 
2.40 ± 0.07 
b 
GA 50 + FM 
20 
5.37 ± 0.47 b 83.39 1.18 ± 0.08 
b 
2.63 ± 0.08 
b 
 
GA – Gallic acid; FM – Famotidine. All values are expressed as mean ± S.E.M.; 
(n=6) animals in each group.  aP<0.05, bP<0.01,  c = non significant when ulcer 
control was compared with control untreated animals and gallic acid, famotidine 
and combination drug treated group were compared with ulcer control. 
 
 
 
 
 
 
 
 
Table 2: Action of gallic acid and its combinations on total and 
free acidity, pepsin and DNA concentration of gastric juice 
Group Total 
acidity 
(meq/l per 
100g) 
Free acidity 
(meq/l per 
100g) 
Pepsin 
(µg/ml) 
DNA 
(µg/ml) 
Control 60.33± 
1.43 
38.66 ± 1.93 12.42 ± 0.54 300.67 ± 
20.07 
Ulcer Control 81.83 ± 
1.47b 
52.67 ± 
1.76b 
19.08 ± 
1.01b 
455.00 ± 
12.50b 
GA (200 
mg/kg) 
61.33 ± 
1.12b 
42.67 ± 
1.61b 
12.83 ± 
0.67b 
325.00 ± 
18.90b 
FM (20 mg/kg) 57.80 ± 
1.66b 
38.50 ±1.48b 11.17 ± 
0.51b 
280.01 ± 
12.20b 
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GA 200 + FM 
5 
60.50 ± 
1.83b 
40.66 ± 
1.60b 
12.02 ± 
0.84b 
299.17 ± 
9.78b 
GA 200 + FM 
10 
53.33 ± 
1.12b 
34.66 ± 
0.98b 
10.92 ± 
0.72b 
272.50 ± 
21.90b 
GA 200 + FM 
20 
49.83 ± 
2.21b 
33.00 ± 
1.71b 
8.58 ± 0.85b 229.17 ± 
7.68b 
GA 100 + FM 
5 
61.17 ± 
1.08b 
41.83 ± 1.49a 12.17 ± 
0.49b 
317.50 ± 
9.90b 
GA 100 + FM 
10 
56.00 ± 
1.88b 
37.00 ± 
1.49b 
12.08 ± 
0.60b 
269.17 ± 
9.26b 
GA 100 + FM 
20 
51.33 ± 
1.10b 
33.67 ± 
1.38b 
9.42 ± 0.64b 231.17 ± 
5.94b 
GA 50 + FM 5 68.16 ± 
0.98a 
45.66 ± 0.71a 15.58 ± 
0.83a 
355.60 ± 
14.60a 
GA 50 + FM 
10 
58.50 ± 
2.28b 
38.17 ± 
0.90b 
13.08 ± 
0.66b 
289.16 ± 
9.44b 
GA 50 + FM 
20 
54.17 ± 
1.89b 
36.33 ± 
1.99b 
10.50 ± 
0.70b 
251.65 ± 
11.00b 
 
GA – Gallic acid; FM – Famotidine. All values are expressed as mean ± S.E.M.; 
(n=6) animals in each group.  aP<0.05, bP<0.01, when ulcer control was compared 
with control untreated animals and gallic acid, famotidine and combination drug 
treated group were compared with ulcer control. 
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Table 3:  Activity of gallic acid and its combinations on protein and mucosal carbohydrate content in gastric 
juice of aspirin plus pylorus ligated rats 
Group Total Protein 
(µg/ml) 
Hexosamine 
(µg/ml) 
Hexose 
(µg/ml) 
Fucose 
(µg/ml) 
Control 510.00 ± 17.13 374.17 ± 17.84 340.00 ± 17.84 124.33 ± 2.85 
Ulcer Control 786.67 ± 25.65b 220.83 ± 14.28 b 256.66 ± 13.01b 88.00 ± 3.0b 
GA (200 mg/kg) 526.66 ± 14.98b 357.50 ± 14.76b 328.33 ± 13.45b 120.11 ± 2.92b 
FM (20 mg/kg) 501.56 ± 9.46b 365.83 ± 15.41b 341.66 ± 10.77b 132.67 ± 4.15b 
GA 200 + FM 5 518.33 ± 16.60b 350.00 ± 14.14b 329.16 ± 16.20b 123.67 ± 3.74b 
GA 200 + FM 10 471.66 ± 14.92b 395.00 ± 20.25b 378.33 ± 22.17b 158.66 ± 6.59b 
GA 200 + FM 20 466.67 ± 17.44b 399.17 ± 16.30b 389.16 ± 16.60b 165.17 ± 6.40 b 
GA 100 + FM 5 576.66 ± 11.74b 375.00 ± 8.47b 317.50 ± 4.43b 116.33 ± 3.48b 
GA 100 + FM 10 490.00 ± 29.10b 374.17 ± 17.29b 348.33 ± 11.30b 140.66 ± 2.95b 
GA 100 + FM 20 478.33 ± 12.49b 389.17 ± 16.60b 394.16 ± 10.12b 143.33 ± 1.91 b 
GA 50 + FM 5 570.80 ± 28.38a 300.83 ± 13.13c 301.83 ± 12.21c 109.30 ± 8.73a 
GA 50 + FM 10 500.00 ± 18.07b 370.86 ± 13.63b 298.43 ± 9.87b 130.00 ± 2.90b 
GA 50 + FM 20 486.66 ± 29.74b 377.50 ± 14.19b 360.00 ± 11.62b 129.66 ± 2.74b 
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GA – Gallic acid; FM - Famotidine. All values are expressed as mean ± S.E.M.; (n=6) animals in each group.  aP<0.05, bP<0.01,   
c = non significant when ulcer control was compared with control untreated animals and gallic acid, famotidine and combination drug 
treated group were compared with ulcer control. 
 
Table 4 : Antioxidant activity of gallic acid and its combination in rat stomach tissue 
Group 
SOD 
(μM/min/mg 
protein) 
CAT 
(μM/min/mg 
protein) 
GPx 
(μM/min/mg 
protein) 
GR 
(μM/min/mg 
protein) 
GSH 
(μM/min/mg 
protein) 
G6PD 
(μM/min/mg 
protein) 
Control 1.16 ± 0.02 38.13 ± 1.84 1.38 ± 0.05 0.32 ± 0.01 1.47 ± 0.06 2.65 ± 0.10 
Ulcer Control 0.49 ± 0.01a 31.00 ± 1.07b 0.92 ± 0.29
b 0.24 ± 0.01 a 0.93 ± 0.04a 1.88 ± 0.04b 
GA (200 mg/kg) 1.11 ± 0.14a 37.65 ± 0.33b 1.35 ± 0.16
b 0.31 ± 0.04a 1.40 ± 0.08b 2.41 ± 0.20b 
FM(20 mg/kg) 1.22 ± 0.07b 37.23 ± 2.09b 1.45 ± 0.09
b 0.30 ± 0.02b 1.51 ± 0.10a 2.57 ± 0.06b 
GA 200 + FM 5 1.14 ± 0.24a 37.96 ± 0.27b 1.40 ± 0.15
a 0.36 ± 0.02a 1.39 ± 0.07b 2.50 ± 0.05b 
GA 200 + FM 10 2.12 ± 0.14b 40.70 ± 2.39b 1.71 ± 0.04
b 0.39 ± 0.02b 1.69 ± 0.10b 2.74 ± 0.07b 
GA 200 + FM 20 2.24 ± 0.18b 41.31 ± 1.76± 0.10b 0.48 ± 0.04b 1.98 ± 0.11b 2.91 ± 0.08b 
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2.36b 
GA 100 + FM 5 1.07 ± 0.07b 37.50 ± 0.16b 1.38 ± 0.08
a 0.29 ± 0.03a 1.39 ± 0.06b 2.47 ± 0.04b 
GA 100 + FM 10 1.78 ± 0.10b 38.94 ± 0.82b 1.79 ± 0.14
b 0.36 ± 0.02b 1.76 ± 0.13b 2.67 ± 0.06b 
GA 100 + FM 20 2.16 ± 0.18 b 40.67 ± 0.47b 1.90 ± 0.11
b 0.46 ± 0.03b 1.84 ± 0.20b 2.83 ± 0.08b 
GA 50 + FM 5 1.06 ± 0.05b 36.30 ± 0.31a 1.36 ± 0.07
a 0.28 ± 0.01a 1.21 ± 0.05b 2.37 ± 0.04a 
GA 50 + FM 10 1.29 ± 0.06b 38.63 ± 0.34b 1.46 ± 0.05
b 0.33 ± 0.03a 1.54 ± 0.16b 2.61 ± 0.08b 
GA 50 + FM 20 1.69 ± 0.31b 39.74 ± 0.26b 1.64 ± 0.13
b 0.36 ± 0.04b 1.65 ± 0.19b 2.77 ± 0.08b 
 
GA – Gallic acid; FM - Famotidine. All values are expressed as mean ± S.E.M.; (n=6) animals in each group.  aP<0.05, bP<0.01, when 
ulcer control was compared with control untreated animals and gallic acid, famotidine and combination drug treated group were 
compared with ulcer control. 
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Table 5:  Anti-lipid peroxidative indices and MPx activities in 
aspirin plus pylorus ligated rats stomach homogenate treated with 
gallic acid and its combinations 
Group TBARS 
(nM/min/mg 
protein) 
HP 
(nM/min/mg 
protein) 
MPx 
(μM/min/mg 
protein) 
Control 3.75 ± 0.10 6.00 ± 0.23 2.31 ± 0.16 
Ulcer Control 6.07 ± 0.20b 9.29 ± 0.42b 3.79 ± 0.18b 
GA (200 
mg/kg) 
3.81 ± 0.16b 6.65 ± 0.15b 2.42 ± 0.11b 
FM (20 mg/kg) 3.57 ± 0.26b 6.42 ± 0.26b 2.01 ± 0.15b 
GA 200 + FM 5 3.68 ± 0.22b 6.68 ± 0.18b 2.25 ± 0.17b 
GA 200 + FM 
10 
2.58 ± 0.23b 4.58 ± 0.27b 1.63 ± 0.14b 
GA 200 + FM 
20 
2.96 ± 0.16b 4.92 ± 0.12b 1.33 ± 0.15b 
GA 100 + FM 5 3.71 ± 0.19b 6.80 ± 0.09a 1.98 ± 0.10b 
GA 100 + FM 
10 
3.03 ± 0.12b 5.25 ± 0.14b 1.76 ± 0.17b 
GA 100 + FM 
20 
2.61 ± 0.23b 4.60 ± 0.15b 1.35 ± 0.14b 
GA 50 + FM 5 4.42 ± 0.10b 7.26 ± 0.09a 2.99 ± 0.13a 
GA 50 + FM 10 3.41 ± 0.11b 6.09 ± 0.17b 1.95 ± 0.09b 
GA 50 + FM 20 3.12 ± 0.14b 6.21 ± 0.08b 1.74 ± 0.11b 
 
GA – Gallic acid; FM - Famotidine. All values are expressed as mean ± S.E.M.; 
(n=6) animals in each group.  aP<0.05, bP<0.01, when ulcer control was compared 
with control untreated animals and gallic acid, famotidine and combination drug 
treated group were compared with ulcer control. 
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Table 6:  Antioxidant parameters in liver tissue homogenate treated with gallic acid and its combination in 
pylorus ligated rats 
Group 
SOD 
(μM/min/mg 
protein) 
CAT 
(μM/min/mg 
protein) 
GPx 
(μM/min/mg 
protein) 
GR 
(μM/min/mg 
protein) 
GSH 
(μM/min/mg 
protein) 
G6PD 
(μM/min/mg 
protein) 
Control 2.96 ± 0.22 81.48 ± 3.45 2.71 ±0.17 0.64 ± 0.06 3.67 ± 0.16 4.89 ± 0.26 
Ulcer Control 1.22 ± 0.07b 70.23 ± 
1.97a 
1.81 ± 0.09a 0.34 ± 0.03b 2.03 ± 0.10b 2.98 ± 0.06b
GA (200 mg/kg) 2.95 ± 0.14b 80.52 ± 
0.43a 
2.51 ± 0.13a 0.58 ± 0.06b 3.58 ± 0.14a 4.71 ± 0.10b
FM(20 mg/kg) 3.08 ± 0.17b 80.97 ± 
4.56b 
2.66 ± 0.15b 0.62 ± 0.03b 3.76 ± 0.33b 4.58 ± 0.09b 
GA 200 + FM 5 2.98 ± 0.19b 80.76 ± 
2.20b 
2.61 ± 0.23b 0.79 ± 0.03b 3.85 ± 0.21a 4.99 ± 0.11b
GA 200 + FM 10 3.44 ± 0.18b 83.02 ± 
2.91b 
3.83 ± 0.11b 0.90 ± 0.04b 4.80 ± 0.16b 5.02 ± 0.09b
GA 200 + FM 20 3.87 ± 0.14b 83.32 ± 
3.07b 
3.92 ± 0.10b 1.11± 0.06b 5.56 ± 0.13b 5.31 ± 0.16b
GA 100 + FM 5 2.87 ± 0.15b 80.56 ± 
1.58b 
2.56 ± 0.12b 0.51 ± 0.03a 3.50 ± 0.07a 4.64 ± 0.08b
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GA 100 + FM 10 3.47 ± 0.13b 82.46 ± 
1.36b 
2.99 ± 0.24b 0.75 ± 0.06b 4.37 ± 0.21b 5.06 ± 0.07b
GA 100 + FM 20 3.50 ± 0.15b 82.67 ± 
0.37b 
3.36 ± 0.12b 0.98 ± 0.10b 4.84 ± 0.25b 5.11 ± 0.07b
GA 50 + FM 5 1.97 ± 0.18a 79.80 ± 
1.12a 
2.30 ± 0.04a 0.50 ± 0.03a 2.98 ± 0.07a 4.01± 0.13b 
GA 50 + FM 10 3.15 ± 0.09b 81.19 ± 
1.13b 
3.21 ± 0.06b 0.57 ± 0.07b 4.11 ± 0.17b 4.72 ± 0.10b
GA 50 + FM 20 3.38 ± 0.09b 82.06 ± 
1.16b 
3.80 ± 0.23b 0.73 ± 0.08b 4.63 ± 0.11b 4.86 ± 0.09b
GA – Gallic acid; FM - Famotidine. All values are expressed as mean ± S.E.M.; (n=6) animals in each group.  aP<0.05, bP<0.01, when 
ulcer control was compared with control untreated animals and gallic acid, famotidine and combination drug treated group were 
compared with ulcer control.
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Table 7: Effect of gallic acid alone and in combination on lipid 
peroxidation indices and MPx activities in aspirin plus pylorus 
ligated liver tissue. 
Group 
TBARS 
(nM/min/mg 
protein) 
HP 
(nM/min/mg 
protein) 
MPx 
(μM/min/mg 
protein) 
Control 3.43 ± 0.79 11.14 ± 0.40 3.86 ± 0.19 
Ulcer Control 9.79 ± 0.45b 15.86 ± 0.62b 5.96 ± 0.35b 
GA (200 
mg/kg) 
6.83 ± 0.15b 11.91 ± 0.18b 3.67 ± 0.22b 
FM (20 
mg/kg) 
6.10 ± 0.36b 11.66 ± 0.63b 3.26 ± 0.29b 
GA 200 + FM 
5 
6.73 ± 0.05b 11.28 ± 0.36b 3.46 ± 0.19a 
GA 200 + FM 
10 
4.88 ± 0.34b 10.17 ± 0.29b 2.68 ± 0.17b 
GA 200 + FM 
20 
3.51 ± 0.12b 9.57 ± 0.21b 2.44 ± 0.11b 
GA 100 + FM 
5 
5.13 ± 0.10b 11.11 ± 0.20a 3.53 ± 0.13a 
GA 100 + FM 
10 
5.77 ± 0.07b 10.54 ± 0.23b 2.79 ± 0.12b 
GA 100 + FM 
20 
4.03 ± 0.05b 10.21 ± 0.19b 2.51 ± 0.10b 
GA 50 + FM 5 8.34 ± 0.19b 12.92 ± 0.11a 4.02 ± 0.07a 
GA 50 + FM 
10 
6.89 ± 0.31b 11.43 ± 0.16b 3.32 ± 0.12b 
GA 50 + FM 
20 
6.82 ± 0.13b 10.51 ± 0.14b 2.93 ± 0.22b 
 
GA – Gallic acid; FM - Famotidine.  All values are expressed as mean ± S.E.M.; 
(n=6) animals in each group.  aP<0.05, bP<0.01, when ulcer control was compared 
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with control untreated animals and gallic acid, famotidine and combination drug 
treated group were compared with ulcer control. 
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Fig. 5:  Stomach of a) untreated control rats ; b) ulcer control rats ;   
c)  famotidine treated rats ; d) gallic acid  treated rats; e)  GA 200 + FM 5 
treated rats ; f) GA 200 + FM 10 treated rats. 
5 e 5 f 
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Fig. 6:  Stomach of a) GA 200 + FM 20 treated  rats ; b) GA 100 + FM 5 
treated  rats;  c)  GA 100 + FM 10 treated  rats; d) GA 100 + FM 20 treated  
rats; e)  GA 50 + FM 5 treated  rats; f) GA 50 + FM 10 treated rats. 
 
6 a 6 b 
6 c 5 d 6
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Fig. 7:  Stomach of a, GA 50 + FM 20 treated rats. 
 
 
 
 
 
 
 
Fig. 8: Histopathological examination of gastric mucosal tissue section of 
untreated control animals, shows normal gastric mucosa  
(heamatoxylin and eosin, 100x).
7 a 
8 
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Fig. 9: Histopathological examination of gastric mucosal tissue section of  
a) ulcerated stomach, shows erosion with distorted gastric glands and 
damaged mucosal epithelium with inflammation and congestion; b) section of 
famotidine treated stomach, shows mild inflammation of submucosa;  
c) section of gallic acid treated stomach shows gastric mucosa with mild 
inflammation and congestion of submucosa (heamatoxylin and eosin, 100x). 
9 a 
9 b 
9 c 
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Fig. 10:  Histopathological  examination of  gastric mucosal tissue section of 
a) GA 200 + FM 5 treated animal stomach, shows mild inflammation of the 
lamina propria and sumucosa; b) section shows mild inflammation of 
mucosa, there is no evidence of ulceration, in the gastric mucosa of rats after 
treatment with GA 200 + FM 10; c) section shows congestion of mucosa, 
10 a 
10 b 
10 c 
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there is no evidence of ulceration, in the gastric mucosa of rats after 
treatment with GA 200 + FM 20 (heamatoxylin and eosin, 100x). 
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Fig. 11: Histopathological examination of gastric mucosal tissue section of  
a) section shows gastric tissue with focal inflammation of submucosa after 
treatment with GA 100 + FM 5; b) section of GA 100 + FM 10 treated 
stomach, hows inflammation of submucosa no ulcer was found; c) section 
shows gastroesophagal junction with no ulceration after treatment with GA 
100 + FM 20 (heamatoxylin and eosin, 100x). 
11 a 
11 b 
11 c 
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Fig. 12: Histopathological examination of gastric mucosal tissue section of  
a) section of GA 50+ FM 5 treated stomach, shows inflammation of and 
congestion of submucosa and lamina propria ; b)  section of GA 50+ FM 10  
treated stomach, shows gastric mucosa with mild inflammation and edema of 
submucosa; c) section shows mild inflammation and congestion of gastric 
mucosa after treatment with GA 50 + FM 20 (heamatoxylin and eosin, 100x). 
12 a 
12 b 
12 c 
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6. DISCUSSION AND CONCLUSION 
In the present study antiulcer effect of the phytoconstituent 
gallic acid alone and in combination with known antiulcer drug 
famotidine was investigated in aspirin plus pylorus ligation induced 
ulcer in rats. NSAIDs like aspirin interfere prostaglandin synthesis 
through cyclooxygenase pathways and produce neutrophil and oxygen 
radical dependent microvascular injury leading to mucosal damage 
(Jafri et al., 2001; Maity et al., 1995; Pal and Chaudhuri, 1991). 
Aspirin acts directly by increasing the H+ ion transport while on the 
mucosal epithelial cells, it decreases mucin, surface-active 
phospholipids, bicarbonate secretion (Sairam et al., 2003). In pylorus 
ligated rats accumulation of gastric acid and pepsin secretion are 
important factors for generation of ulceration. When aspirin was 
administered to pylorus ligated rats, it further aggravated the acidity 
and the resistance of the gastric mucosa was decreased thereby 
imposing extensive damage to the glandular region of the stomach 
(Sanmugapriya and Venkataraman., 2007; Dharmani et al., 2004). The 
protective effect of gallic acid as evidenced by percentage inhibition 
of ulcer against aspirin induced gastric lesions could be due to its 
cytoprotective effect. 
Treatment with gallic acid and its combinations decreased the 
ulcer index compared to ulcer control group, which is the direct 
indication of its antiulcer activity. Gallic acid and combination 
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treatment also decreased volume of acid secretion, peptic activity, 
total and free acidity and increased pH of the gastric juice compared to 
ulcer control group proving the antiulcer activity of gallic acid.  
 Mucus act as defensive factor by preventing physical damage 
to mucosa leading to lesser degree of ulceration (Sairam et al., 2002). 
The individual carbohydrates such as hexoses, fucose and hexosamine 
concentrations are the index of mucin content in gastric juice (Annop 
and Jegadeesan, 2003). Aspirin plus pylorus ligated rat group showed 
a decrease in the concentration of hexoses, hexosamine and fucose 
which was reversed by gallic acid and its combinations. 
Administration of gallic acid resulted in a significant increase in 
glycoprotein content in gastric mucosa and a net increase in synthesis 
of mucus contributing to its ulcer protective role.  
Increase in protein content of gastric juice resulted in a decrease 
in total carbohydrate and protein ratio in aspirin plus pylorus ligated 
rat leading to the damage of gastric mucosa (Jainu et al., 2006). 
Pretreatment with gallic acid, famotidine and their combinations 
decreased the plasma protein leakage from gastric mucosa by 
strengthening the mucosal barrier. The decrease in protein contents of 
gastric juice by the drugs lead to an increase of total 
carbohydrate/protein ratio proving the efficacy of combination 
treatment. 
The strengthening of mucosal defense is further exemplified by 
decrease in cell exfoliation as seen from the reduction in DNA content 
of the gastric juice (Mukhopadhyaya et al., 1987). The reduced level 
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of DNA in all the drug treated groups further suggests the increase in 
mucosal defense capacity of the gallic acid. 
Free radicals are detrimental to the integrity of biological tissue 
and mediate their injury (Demir et al., 2003). It is now generally 
agreed that among various mechanisms, oxidative damage of the 
gastric mucosal cell membrane by ROS is the major causative factor 
for gastric ulceration. This decreases the membrane permeability, 
activities of enzyme and receptors and activation of cells. Drugs that 
scavenge or inhibit the generation of ROS may be effective in the 
prevention of gastric damage (Halici et al., 2005; Huh et al., 2003). 
Antioxidants constitute the foremost defense system that limit the 
toxicity associated with free radicals. Gallic acid possess potent 
antioxidant property (Yen et al., 2002), therefore in the present study 
the antioxidant levels in stomach and liver tissue was investigated to 
know the protective role of gallic acid in gastric ulcers. 
SOD catalyses the reduction of superoxide anion (O2● -) to H2O2 
and O2 while CAT converts H2O2 to water and molecular oxygen 
preventing the oxidative damage (Machado-Vieira et al., 2007; Sairam 
et al., 2003). GPx calalyses the oxidation of GSH to oxidized 
glutathione (GSSG) at the expense of H2O2 and convert it to water. 
GSSG can be reduced to GSH by GR in presence of NADPH (Liu et 
al., 2007; Ali et al., 1996). The decrease in antioxidant enzymes levels 
lead to accumulation of ROS by increasing lipid peroxidation. 
Depletion in SOD, CAT, GR, GPx were observed in the pylorus 
ligated stomach and liver tissue homogenates. Gallic acid and its 
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combination with famotidine significantly increased the level of these 
antioxidant enzymes proving the gastroprotective action by its 
antioxidant defense mechanism. 
GSH present in the stomach plays an important role in 
maintaining the gastric mucosal cell integrity. GSH depletion is 
associated with generation of gastric lesion in the rats. GSH is a non 
enzymatic component and has a central role in antioxidant network 
(Anandan et al., 1999; Altinkaynak et al., 2003). In pylorus ligated 
stomach, decreased GSH level was observed while in drug treated 
groups an elevated level was noticed substantiating its antioxidant 
property. A similar increase was also observed in liver tissue 
homogenate. 
Infiltration of neutrophils into gastric mucosal tissue is a critical 
process in the pathogenesis of gastric ulcer and can be checked by 
MPx activity. MPx mediates lipid peroxidation in the presence of 
H2O2 and Cl−. Increase in MPx show an increase in level of neutrophil 
infiltration into gastric damage tissue (Ohata et al., 1999; Odabasoglu 
et al., 2006). An increase in level of MPx was observed in the pylorus 
ligated stomach tissue and upon administration of gallic acid and its 
combinations, decreased MPx levels thereby protecting the rats from 
gastric damage. 
Increased lipid peroxidation is one of the major indications of 
ROS generation in gastric mucosa accompanied by increase of 
TBARS and HP (Jainu and Devi, 2006; Bafna and Balaraman, 2005). 
Our data also shows ameliorative increase of lipid peroxides in 
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pylorus ligated aspirin induced ulcers in rats liver and stomach 
homogenate. Treatment with gallic acid and its combination resulted 
in suppression in the levels of TBARS and HP. Polyhydroxy phenolic 
substances like gallic acid having potent antioxidant properties are 
anticipated to exert protective effects on ulceration. 
 G6PD is a cytoplasmic enzyme and acts as a supporter of the 
primary antioxidant enzymes. It provides coenzymes and substrate to 
the primary antioxidant enzymes thus playing a protective role against 
ROS induced oxidative stress. G6PD can slow down the production of 
cytosolic NADPH by controlling the step from glucose-6-phosphate to 
6-phospho-gluconate in pentose phosphate pathway (Ramesh and 
Pugalendi, 2006; Agarwal and Rami, 2003). G6PD enzyme level 
significantly decreased (P<0.05) in stomach and liver tissue of aspirin 
plus pylorus ligated rats and were increased by pretreatment with 
gallic acid and its combinations proving the ulcer protective action of 
gallic acid. 
 Antiulcerogenic potential of gallic acid and its combination was 
further evidenced by the histopathological study of stomach tissue. No 
ulceration was observed in higher dose combinations like GA 200 + 
FM 20, GA 200 + FM 10, GA 200 + FM 10 and mild inflammation of 
submucosa or congesion of submucosa was observed in other 
treatment groups, suggesting the antiulcer activity of gallic acid and its 
combinations. 
In conclusion, all these result suggest that gallic acid has a 
gastroprotective effect on gastric lesion induced by aspirin plus 
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pyrolus ligation. Ulcer healing effect of gallic acid may be due to its 
increased mucosal defensive and decreased offensive factors. Gallic 
acid also effectively quenches the free radicals and LPO and positively 
modulates antioxidant status. The antioxidant property of the test drug 
might contribute to its antiulcerogenic activity.  Combination of both 
gallic acid and famotidine showed good antiulcer activity, suggesting 
the interaction of both agents in protection of ulcer. 
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